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ABSTRACT
HEALTH AND HUMAN CAPITAL EFFECTS OF LEAD EXPOSURE
The legacy of lead in the United States is complex and intertwined with public health. As
concerns over the toxicity of lead increased with time, policy makers responded with a series of
national policies aimed at minimizing the risk of lead exposure across society. One such policy,
the Clean Air Act (CAA), set a timeline for the removal of lead from gasoline beginning in 1975.
This policy would target the anti-knock lead additive tetraethyl-lead (TEL), which was used to
boost gasoline octane and improve engine performance (Needleman, 2000; Reyes, 2007). Over
the following two decades, the flow of lead entering the environment from automobile emissions
decreased precipitously.
This dissertation exploits a natural experiment in lead exposure arising from the differential
phase-out of leaded gasoline across states under the CAA. Though the policy was implemented
at the national level, enforcement took place at the producer level, creating exogenous variation
in lead emissions from automobile exhaust across states and over time. Since lead dust from
automobile emissions was a significant source of lead exposure over the period, we leverage this
spatial and temporal variation as a quasi-random vector of lead exposure.
Chapter one summarizes the CAA, and the historical significance of the policy as it relates
to public health. Using blood lead levels (BLLs) from The Second National Health Nutrition
and Exercise Survey (NHANESII) as a bio-marker for lead exposure, this paper models the lead
exposure effect of the policy. Combining annual gasoline sales and gasoline lead concentrations at
the state level, the steps taken to construct the variables proxying for lead exposure following the
CAA are detailed at length. The empirical strategy applied in this chapter is used to identify the
causal effect of the phase out on lead exposure, and is carried over in the following two chapters.
Much of the research focusing on the effects of lead exposure emphasize the risk faced by
children, who are particularly susceptible to even minute quantities in the first five years of life.
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Chapter two tests the hypothesis that lead exposure in childhood impacts cognitive ability and the
presence of abnormal latent preferences toward risk and uncertainty in adulthood. Applying the
identification strategy detailed in Chapter one, to a nationally representative sample of individuals
born during a period of significant reductions in leaded gasoline emissions, we find considerable
evidence supporting the causal effect of childhood lead exposure and later in life outcomes. Across
a series of tests, we find that BLLs in childhood are a significant predictor of: 1) IQ loss, measured
with standardized test scores; 2) increased likelihood of low-IQ outcomes in exposure levels; and
3) increased abnormal risk response across a series of situations involving uncertain outcomes.
The results presented in this paper illustrate the significance and persistent affect of early in life
lead exposure.
An underappreciated medium of child exposure to flow and legacy sources of lead is in-utero
transmission of lead from mother to infant. Transmission of lead to the fetus occurs via diffusion
across the placental barrier over the course of a pregnancy. Chapter three estimates the causal effect
of maternal lead exposure on birth outcomes during the initial period of the phase out. Results
show consistent evidence that fetal exposure to lead through the maternal blood lead pathway
significantly depresses infant health. Our findings suggest that an increase in maternal blood lead:
1) decreases infant birthweight; 2) increases the risk of low and very low birthweight; 3) shortens
gestation length; 4) increases the risk of prematurity; and 5) increases the risk of a low APGAR
score. A back of the envelope calculation of the economic benefits of the phase-out of leaded
gasoline through the reduction of healthcare-related costs involved in treating low birthweight
infants, are in the tens of billions annually.
It might be tempting to assume that lead exposure is a rear-view problem, at least in the United
States, as BLLs in children have fallen since the 1990s, coincident with a series of actions that
banned lead from paint, plumbing, food cans and automotive gasoline. However, the flow of lead
into the environment continues from various point source polluters as well emissions from aviation
gasoline used by an estimated 160,000 piston-engine aircraft (Kessler, 2013). Though the benefits
to public health attributable to national policies are immense, the stock of legacy lead and present
day flow sources of environmental lead remain a persistent threat to public health.
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The Clean Air Act and the phase out of leaded
gasoline: The effects of national policy on lead
exposure and automobile emissions
1.1 Introduction
As modern science has deepened our understanding of the toxicity of lead, it has motivated
national policies aimed at minimizing the public health hazard this element poses to society. This
chapter will retrace the path over which the Clean Air Act (CAA) of 1970 would phase out the
use of lead additives in automobile gasoline sold to consumers. The direct result of the policy was
significant reductions in the volume of atmospheric lead and immense benefits to public health as
the risk of lead exposure would decline for all socioeconomic and demographic groups. Though
national policies such as the CAA have resulted in significant reductions in the quantities of lead
entering the environment from the consumption of products containing lead, the legacy of past use
continues to impact people to this day, and will likely extend well into the future.
To identify the causal channel linking gasoline lead to lead exposure, we exploit the phase out
of lead from gasoline as an exogenous source of variation in lead emissions at a national scale. Un-
der the CAA, a time line for the removal of lead from gasoline was implemented beginning in 1975.
Over the following two decades, lead entering the environment from automobile emissions would
fall precipitously. Though the policy was enforced at the national level, the incentive structure for
compliance, as well as the characteristics of the petroleum and automobile industries, would result
in significant variation in lead emissions across states between 1975 and 1990. Since lead dust
resulting from the consumption of leaded gasoline was among the primary vectors of lead expo-
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sure in children over this period,1 we use state and year variation in gasoline lead concentrations
to identify our empirical model, and proxy for this exposure channel.
This paper contributes to the body of literature investigating the link between lead exposure
and environmental externalities. Modeling the causal relationship between automobile emissions
and lead exposure at a national scale, our findings are a novel contribution to prior research in this
domain. Results from this analysis show that gasoline lead levels are a statistically significant pre-
dictor of blood lead levels during the period following the CAA. At a national level, the estimated
marginal effect of reductions in gasoline lead concentrations is a decline in blood lead levels. We
show these results persist across a series of sensitivity and robustness tests, as well as for both
children and adults. Furthermore, to demonstrate the robustness of this identification strategy, we
include the results of a divergent validity test of the identifying assumptions underlying the empir-
ical analysis in this chapter and those that follow. Across this ensemble of evidence, our findings
illustrate the considerable improvements in public health following the CAA.
The remainder of the chapter is laid out as follows: Section 1.2 details the widespread use of
lead in the United States as it relates to public health and national policies. A summary of the data
used and empirical methods are found in Section 1.3. Results are presented in Section 1.4 and the
paper closes with a discussion and conclusion as they relate to the following chapters are found in
Section 1.5.
1.2 Lead use and national policy
Historically, lead has been used in a variety of applications due to its desirable chemical prop-
erties, resulting in widespread use in the manufacturing of goods and productive services (Nevin,
2000; Needleman, 2004; Papanikolaou et al., 2005). Two use cases which accounted for nearly
all lead used in the United States over the last century were as an additive to paint and gasoline.
Figure 1.1 illustrates the magnitude of demand for these products as total tonnages during the 20th
century. Together, the consumption of these products resulted in the distribution of lead across the
United States.
1See Bellinger and Bellinger (2006), Abadin et al. (2007), Mielke and Reagan (1998) among others.
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Figure 1.1: US lead use, 20th century (source: Laidlaw and Filippelli (2008))
The period of U.S. history in Figure 1.1 is historically significant for two reasons. First, the
emergence of the automobile industry, along with the completion of an interstate highway system,
created significant increases in demand for petroleum products, specifically automobile gasoline.
At the time, gasoline sold to consumers was formulated with tetraethyl-lead (TEL), an anti-knock
additive used to boost octane and improve engine performance (Needleman, 2000; Reyes, 2007).
The steady increase in lead production shown in Figure 1.1 between 1930 to 1970 was driven
by demand for leaded gasoline and accounts for the majority of the flow of lead entering the
environment. Mielke and Reagan (1998) have estimated that the amount of lead used in gasoline
between 1929 to 1990 is about as much as the amount used in paint between 1884 to 1989.
Second, this period marked a shift in public opinion with respect to the toxicity of lead and the
hazard this element posed to public health. A growing body of evidence linking lead to adverse
health outcomes, particularly in children, would ultimately result in policies aimed at minimizing
the health risks created by leaded products (Needleman, 2000; Papanikolaou et al., 2005; Bellinger
and Bellinger, 2006). The first set of policies targeted leaded paint, and resulted in the removal
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of lead from interior paints in 1971, and all paints in 1978 (Mielke and Reagan, 1998). Shortly
thereafter, the CAA would target air pollution and regulate lead emissions from the use of leaded
gasoline. As evident in Figure 1.1, the dramatic decline in paint beginning around 1925 is largely
attributable to the public’s awareness of the hazards lead paint created for children, and the decline
in gasoline beginning around 1975 attributable to national policy.
1.2.1 Lead exposure and health outcomes
Perhaps the most underappreciated source of lead exposure is contaminated soil or dust. In
the United States, the most common channel of non-occupational lead exposure is through the
ingestion or inhalation of lead dust (Abadin et al., 2007), and the risk of exposure through this
vector of exposure is widespread. Urban soils integrate all dust sources of Pb including lead-based
paint (either deteriorated, haphazardly removed by power sanding, sand blasted, scraped without
capture, or released by building demolition), lead additives in vehicle fuel emissions, and industrial
Pb emissions (Mielke et al., 1999; Mielke and Reagan, 1998; Mielke and Zahran, 2012; Farfel
et al., 2005a; Rabito et al., 2007). The combustion of leaded gasoline in automobiles emits Pb
particulates, with roughly 75% of the lead in gasoline released in the exhaust (Mielke and Reagan,
1998). In all cases, the Pb dust coats surfaces as a residue and mixes with topsoil. Soil Pb at or
near the surface is an exposure risk to humans through direct contact or re-suspension of Pb in
contaminated soils during summer periods (Reagan and Silbergeld, 1989; Filippelli et al., 2005;
Laidlaw et al., 2005, 2012; Zahran et al., 2013).
The magnitude of automobile emissions as a flow source of atmospheric Pb is illustrated in
Figure 1.2, which graphs national automobile lead emissions between 1950 to 1990. Prior to the
phase out, the flow of atmospheric Pb from TEL emissions would exceed 200 thousand metric tons
annually. In the four year period from 1976 to 1980, identified by the verticle bars in Figure 1.2,
all states experienced reductions in gasoline-related Pb emissions of at least 40%, largely driven
by reductions in the TEL concentration of gasoline sold. Given the tendency for lead dust to
re-mobilize, lead exposure attributable to automobile emissions is not limited to those living in
the vicinity of roadways or the source of emissions itself (Zahran et al., 2013; Curci and Masera,
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Figure 1.2: US total gasoline lead (TEL) emissions, metric tons
2017). Compared to lead paint, which to date is largely confined to old homes in low-income areas,
legacy lead from automobile emissions is not limited to geographic or socioeconomic groups, nor
is it simply a rear-view problem.
While both paint and gasoline have left legacy lead, which remains a persistent threat to public
health, the risk posed by each source can vary significantly. When comparing the amount of lead
absorbed by the body after being ingested, the amount entering the bloodstream is non-linear and
inversely related to the size of the particulate consumed (Mielke and Reagan, 1998; Papanikolaou
et al., 2005; Bellinger and Bellinger, 2006). In contrast to deteriorating paint, the health hazard
posed by the lead dust generated by automobile emissions is of much finer granularity, and readily
mobilized once in the body (Mielke and Reagan, 1998; Papanikolaou et al., 2005). So, while paint
chips are a high dose source with respect to lead concentrations, there is a growing consensus that
lead dust created by automobile emissions is a greater hazard to public health (Needleman, 2004;
Toscano and Guilarte, 2005; Nilsson, 2009; Miranda et al., 2011).
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The impact of lead entering the body through ingestion or inhalation varies depending on the
physical characteristics of the individual, and importantly, one’s age. For a given quantity of lead
ingested, the percentage which is absorbed into the bloodstream for adults is roughly 6%, and up-
wards of 50% for children (Clay et al., 2018). Lead which does not make its way into the blood
stream is passed in solid waste or urine. While adults pass nearly all the lead entering their bodies
within several weeks, less than 40% leaves the body of a child during that time (Abadin et al.,
2007). Lead which has entered the bloodstream is then transported throughout the body and de-
posited in soft tissue, bones, or blood plasma. The half life of lead in the bloodstream is estimated
to be 35 days, and is expected to be longer in children (Needleman, 2004; Papanikolaou et al.,
2005; Toscano and Guilarte, 2005). Lead in organs and soft tissues has a half-life of approxi-
mately 40 days (Papanikolaou et al., 2005), though deposits in the brain have been found to have a
half-life of roughly two years (Lidsky and Schneider, 2003). Lead which is deposited in bones and
teeth, can remain for up to 30 years, and has been shown to re-mobilize during periods of reduc-
tion in bone density and re-enter the bloodstream (Needleman, 2004; Papanikolaou et al., 2005).
For example, studies have found elevated blood lead levels (BLLs) in women during pregnancy
and while nursing (Rothenberg et al., 1994; Papanikolaou et al., 2005), as well as postmenopausal
osteoporosis (Bellinger et al., 1987; Needleman, 2004; Bellinger, 2011).
Though the medical profession has had a basic understanding of the toxicology of lead dating
back to antiquity (Needleman, 2004; Toscano and Guilarte, 2005; Bellinger and Bellinger, 2006),
recent studies continue to present new evidence on the extent to which even low-level lead expo-
sure impacts health. While lead poisoning occurs at high levels of exposure, typically observed
at BLLs in excess of 50 micro-grams per deciliter of (µg/dL) (Abadin et al., 2007), evidence
shows that moderate and low-level exposure still poses an immediate hazard, with lasting adverse
health outcomes. Researchers have linked conditions such as hypertension, renal impairment, as
well as a number of cardiovascular complications in adults to moderate levels of lead exposure,
ranging from 20 to 40 µg/dL of blood (Abadin et al., 2007; Bellinger, 2011). In children, the
dose-responsiveness of lead and adverse health outcomes is more severe. In 2012, the Centers for
Disease Control and Prevention (CDC) updated their BLL reference value for at-risk children. In
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response to recommendations made by The Advisory Committee on Childhood Lead Poisoning
Prevention, the CDC set what is now the accepted BLL threshold value of 5 µg/dL, half if the pre-
vious value, acknowledging that to date “no safe blood lead level in children has been identified”
(CDC, 2019). This perspective is echoed in a number of studies which emphasize the marginal
impacts of increases in blood lead levels on IQ loss, school performance, and neuropsychological
impairment (Bellinger et al., 1987; Needleman and Bellinger, 1991; Toscano and Guilarte, 2005;
Bellinger, 2008). Bellinger (2008) finds children with prior acute lead exposure exhibit abnormal
behaviors such as irritability, impatience, and aggression which persist after BLLs return to pre-
exposure levels. Moreover, preliminary evidence suggests that the intellectual impairments caused
by early childhood lead exposure persist into adulthood. Reuben et al. (2017) report that adults
raised in the era of widespread leaded gasoline use experienced significant reductions in IQ and
deficits in perceptual reasoning and working memory, with a strong positive relationship between
childhood blood lead levels and cognitive loss in adulthood.
1.2.2 Variations in lead emissions and the Clean Air Act
Though the Clean Air Act set a national standard, compliance was determined at the pro-
ducer level. As a result, variations in state level gasoline lead concentrations were influenced by
a number of factors relating to the petroleum and automobile industries rather than state specific
environmental policy (Reyes, 2015). Such factors include refinery locations, transportation and
distribution networks, as well as the age of the automobile stock. These characteristics were used
by the Petroleum Administration for Defense (PAD) in 1950 to define 17 distinct districts, across
five regions within the United States (Shelton, 1979). The boundaries of each PAD district (PADD)
are mapped in Figure 1.3, and reflect the geographic definitions recognized during the phase out.
Originally defined during World War II for the purposes of distributing oil throughout the county,
the PAD districts shown in Figure 1.3 reflect the connection between petroleum industry resources
and proximity to population centers.
Evidence of the geographic and temporal variation in gasoline lead attributable to the enforce-
ment of the CAA is shown in Figure 1.4 which follows average gasoline TEL concentrations by
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Figure 1.3: Petroleum Administration for Defense (PAD) district boundaries
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Figure 1.4: Gasoline lead concentrations by PAD district and gasoline grade, 1950-1990
PAD district and leaded grade sold. One PAD district from each of the common geographic re-
gions across the United States has been emphasized for clarity, with remaining PAD districts show
in gray. Panel A in Figure 1.4 is restricted to leaded-premium grade gasoline while Panel B is
leaded-non-premium gasoline. The onset of the phase out of lead from gasoline in 1975 resulted
in the general downward trend in TEL concentrations across all districts and both leaded gasoline
grades. Over the four-year period of interest (1976 to 1979), much of the historic phase out of
leaded gasoline occurred. Nationally, average gasoline lead concentrations would decline approx-
imately 56% over this period, and 85% between 1976 to 1985. However, the interconnectedness
of the petroleum industry to the administrative boundaries shown in Figure 1.3, coupled with the
incentive structures of the policy itself, would have a direct affect on gasoline lead concentrations
at the local level during the phase out. Authors have argued that together, these forces resulted in
random variations in rate of decline in TEL averages across PAD districts during each year of the
phase out, evident in Figure 1.4 (Reyes, 2007, 2015). We leverage this quasi-random variation in
gasoline lead concentrations, occurring during the years 1976 to 1980, and varying exogenously
nationwide, as the identification strategy for estimating the causal relationship between environ-
mental lead from automobile emissions and lead exposure.
1.3 Methods
Based on the findings of Reyes (2007, 2015), petroleum industry experts and historical ac-
counts detailing the characteristics of the petroleum industry, the standards imposed following the
CAA induced significant and quasi-random variations in gasoline lead (TEL) concentrations at
the state level. Furthermore, given the goal of the CAA and the timeline proposed by the EPA to
phase out TEL from gasoline, state level TEL concentrations would vary significantly over time.
As gasoline TEL concentrations declined, lead entering the environment from automobile emis-
sions fell. Since automobile emissions were the primary source of lead pollution, the risk of lead
exposure would decline in both automobile emissions and gasoline TEL concentrations during the
phase out of leaded gasoline. This spatial and temporal variation in gasoline lead concentrations
sold to consumers, and ultimately the primary source of lead emissions entering the environment
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over this period would have a direct impact on the risk of lead exposure across the U.S.. To esti-
mate the causal effect of the policy shock, we use blood lead data and a time series of annual, state
averaged TEL concentrations in the years following the CAA.
1.3.1 Data and measurement
Blood lead
Blood lead measurements are drawn from the Second National Health and Exercise Survey
(NHANESII), provided by the CDC. This nationally representative survey was intended to pro-
vide a detailed analysis of overall health across the nation (NCHS, 1982). Approximately 20,000
individuals, aged 6 months to 74 years old, were surveyed between February, 1976 and February,
1980. Demographic, socioeconomic, employment and household characteristics were collected
alongside a full biochemistry and physiological analysis to deliver a complete inventory of Amer-
ican health at the time.
A subset of respondents were selected for additional testing of hematology and biochemistry,
including blood and urine assessments. The selection criteria for laboratory analysis included all
children between six months and six years old, along with half of the remaining sample aged 7
to 74 years old (NCHS, 1982). In all, blood was collected and analyzed from 10,049 individuals
of the full sample. Descriptive statistics for the sample of NHANESII respondents which were
selected and participated in the blood analysis are found in Table 1.1. The outcome of interest
is respondent’s blood lead levels (BLLs) measured as micro-grams-per-deciliter (µg/dL). Control
variables from the data include the respondent’s age, sex, racial status, and household income to
poverty ratio.2
2The respondent’s age (Age) is measured in years. Indicators for sex and racial status are defined as Female = 1
and Black = 1 if the respondent identifies as African American. Indicators for income group are constructed from
the household income to Federal Poverty Level (FPL) ratio data in the NHANESII data set. We apply the same
definitions of Reyes (2015), with the indicator variable Low=1 for household income < 2 × FPL and Mid=1 for
values ∈ [2× FPL, 3× FPL.
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Table 1.1: National Health and Exercise Survey II sample descriptive statistics
All Ages Ages 0-6
Panel A Mean Standard Deviation Mean Standard Deviation
Demographics
Age (years) 38.6 20.89 3.4 1.62
Female 51.00% 0.50 0.48% 0.50
Black 12.00% 0.33 18.00% 0.38
Low Income (2x FPL) 34.00% 0.47 50.00% 0.50
Middle Income (2x to 3x FPL) 26.00% 0.44 29.00% 0.45
Lead Variables
Blood Lead (µg/dL) 13.78 5.88 16.57 7.67
Gasoline Lead (g/gal) 1.46 0.35 1.49 0.35
Sample Size 6,718 2,430
Blood Lead (µg/dL)
Panel B Mean Standard Deviation Mean Standard Deviation
Gasoline Lead (g/gal)
Gasoline Lead Q1 12.15 5.02 14.61 6.49
Gasoline Lead Q2 13.5 5.49 14.78 5.73
Gasoline Lead Q3 14.34 6.33 17.33 7.45
Gasoline Lead Q4 15.29 6.18 19.14 9.38
Notes: Gasoline Lead is annual, state, average tetraethyl-lead (TEL) concentration (g/gal), cor-
responding to year of laboratory examination and state of residence;
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Gasoline lead
To reconstruct a time series of TEL concentrations at the state level we follow the methodology
of Reyes (2007, 2015). A collection of petroleum industry records and government publications are
used to construct a time series of gasoline lead concentrations along with consumer gasoline sales.
To capture the year-over-year effect of the CAA on the amount of lead entering the environment
from gasoline consumption, we calculate the variable of interest TEL as a weighted average of
gasoline sales and TEL concentrations during the phase out. With these data, we are able to
quantify reductions in lead emissions through the composition and consumption of gasoline in the
years following the CAA. Furthermore, the unique characteristics of this data set captures both the
temporal and spatial variations in this hazardous metal at a national level.
The following sections provide a detailed description of each data source. The historical con-
text in which the data was collected and published motivates the methodological decisions made
in constructing the variables used in the analysis that follows.
TEL Concentrations
TEL concentrations for both regular and premium gasoline are sourced from the “Petroleum Prod-
ucts Survey: Motor Gasolines,” published bi-annually by The National Institute for Petroleum
Research (NIPER) under the Department of Energy. Gasoline was sampled each year from 17
different PAD districts across the United States. The boundaries of these districts were defined
based on refinery locations, distribution networks and infrastructure as well as population centers
(Shelton, 1979).
From each PAD district, a dozen samples were collected bi-annually during the summer and
winter months. The chemical composition of each sample was analyzed and reported in corre-
sponding “Summer” and “Winter” reports and included PAD district averages.3 TEL concen-
trations were reported in grams per gallon (g/gal) for both “leaded non-premium” (regular) and
“leaded premium” (premium). Figure 1.5 is an example of the published data, drawn from the
Summer 1979 report, showing the PAD district averages for premium gasoline. The published
3At this time, we have been unable to attain copies of the “Winter” edition for several years within the period of
interest. As such, we only use the TEL concentrations drawn from the “Summer” reports for consistency.
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Figure 1.5: Motor gasoline survey, summer 1979: Premium grade
data shown in Figure 1.5 are the mean values from the set of samples collected and analyzed for
each district. Additional examples from the 1979 report, including both regular and unleaded gaso-
line grades, are found in Appendix Figure C.1 and Figure C.2 respectively. The example data from
the 1979 report has been included as it is representative of the statistics published in the “Petroleum
Products Survey: Motor Gasolines” during the period of interest.
Annual Sales of Leaded Gasoline
Prior to 1972, gasoline was sold to consumers in two leaded grades, regular and premium. Formu-
lated to enhance engine performance, premium contained higher TEL concentrations per gallon
relative to regular. Unleaded gasoline was introduced in 1972, and was made available to con-
sumers as “unleaded non-premium” (regular-unleaded), though “premium-unleaded” gasoline was
not made available until 1981.
Annual gasoline sales for the years 1975-1984 are drawn from the “Yearly Report of Gasoline
Sales, by States” published by Ethyl Corporation. Ethyl was the primary producer and distributor
of the TEL additive used in gasoline from its introduction in the 1920’s, until its removal in 1990.
In cooperation with the petroleum industry, Ethyl published annual marketing reports detailing
the sales volume of various petroleum products available to end users. These reports include
monthly, quarterly, and annual sales of automobile gasoline by grade (millions of gallons) for
both leaded and unleaded grades. The “Yearly Report of Gasoline Sales, by States” serves as the
primary data source for total sales of each grade across all grades between 1975 to 1984. Figure 1.6
graphs national sales volumes of regular and premium gasoline grades between 1950 to 1985, and
illustrates the magnitude of sales during this period. At peak demand, Ethyl reported national sales
volumes of approximately 60 trillion gallons of regular (non-premium) and 35 trillion gallons of
premium annually. If not for the availability of unleaded alternatives and growing sentiment over
the health hazards posed by leaded gasoline, these trends may have continued.
Average gasoline lead calculation
Using the gasoline sales data published by Ethyl Corp, and the gasoline lead concentration
data published by NIPER, we follow the methodology of Reyes (2015) in constructing annual,
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Figure 1.6: US leaded gasoline sales by grade, 1950-1985
state TEL concentrations. This metric is used to estimate the underlying lead exposure channel,
as it connects the marginal effect of reductions in lead emissions from gasoline consumption to a
bio-marker for lead exposure (BLLs).
To construct this metric, we first calculate total gasoline sales (Qjt) for state j in year t,
by summing the total sales of each grade sold. Define the set of years under observation as
T = {1976, ..., 1980} and let J be the set of states.4 During the phase out, gasoline was sold to
consumers in four grades: premium (p), regular (r), premium-unleaded (pu), and regular-unleaded
(ru).5 Let the set of gasoline grades be G = {p, r, pu, ru} and define total sales for grade g as qgjt.
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4We restrict analysis to the lower 48 states, excluding Washington D.C.
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However, since TEL concentrations in both unleaded grades (telpu, telru) are effectively zero, these










This calculation is performed for all j ∈ J and years t ∈ T .
The motivation to use this measure over alternatives is to isolate the effects of the policy shock
while maintaining variations in the lead exposure channel at the state level. Since the CAA directly
targeted gasoline lead concentrations, impacts of the policy are immediate and distinct in the rate
of reduction in TEL concentrations over time and across states. Evidence of this can be seen in
Figure 1.7 which illustrates TEL calculated using Equation 1.3 for all states between the years
1976 to 1985. Interpreted at the state level, Figure 1.7 illustrates the year-over-year decline in
TEL as a result of the policy shock. Intra-state variation over time was driven by the specific
factors, including age of the automobile stock and consumer preferences, though the policy had
a consistent downward trend in TEL year-over-year. The inter-state variation in TEL is evident
when comparing state values by year. Taken together, the affect of the CAA is evident in the
quasi-random variations along these two dimensions.
1.3.2 Empirical model
Using BLLs from NHANESII as a bio-marker for lead exposure, the analysis that follows aims
to estimate the causal affect of the CAA on reducing lead exposure on a national scale. Again,
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Figure 1.7: Average gasoline lead concentrations by state, 1975-1985
18
the CAA aimed to improve national air quality by setting standards for emissions of hazardous
particulates, including lead. To reduce lead emissions from automobile exhaust, the policy targeted
petroleum refiners by regulating gasoline lead concentrations in all grades sold to consumers. Since
nearly all of the lead in automobile gasoline is emitted in the exhaust, the policy would reduce and
eventually stem the flow of lead into the environment from this source. To estimate the affect of this
policy on lead exposure at a national scale, we follow the methodology outlined in Section 1.3.1
and use gasoline lead concentrations as a proxy for lead exposure risk.
To map the affect of the CAA on lead exposure, we restrict our analysis to the years 1976 to
1980 during which the NHANESII survey was conducted and the most dramatic reductions in TEL
would occur. The outcome of interest for individual i in state j and year t is BLLijt, and captures
the observed lead exposure. Then, using Equation 1.3 to calculate annual state average gasoline
lead concentrations (TELjt), the relationship of interest is represented as:
BLLijt = α + β1TELjt + X
′
ijtβ + Γ2M t + Γ1Zt + Γ3Sj + ǫijt (1.4)
where, X is vector of control variables measuring individual characteristics, including respon-
dent’s age, sex, minority status and household income that influence lead exposure outcomes spe-
cific to individual i. A series of indicator variables are included and are relative to the NHANESII
date of laboratory analysis. Mt and Zt are fixed effects corresponding to the month and year of
the blood draw, with January, 1976 constituting the reference month and year respectively. Sj is
the state of residence for i when the blood sample was collected.6
The coefficient of analytic interest is β1, reflecting the marginal change in BLL explained by a
change in TEL. Since BLL is a bio marker for lead exposure, the expectation is that β1 is negative
as lead emissions declined during the period of interest. Evidence of this relationship is shown in
Table 1.2, which summarizes the distribution of mean BLL and TEL at the national level. The
direct effect of the CAA was dramatic year-over-year reductions in lead emissions beginning in
6The reference group for state fixed effects is respondents with Alabama as place of residence.
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Table 1.2: US lead variables, descriptive statistics
Standard 25th 75th
Mean Deviation Percentile Median Percentile N
Gasoline Lead (g/gal)
1976-1980 1.35 0.40 1.01 1.4 1.66 245
1976 1.76 0.20 1.61 1.75 1.87 49
1977 1.64 0.20 1.55 1.66 1.79 49
1978 1.30 0.23 1.18 1.33 1.44 49
1979 1.32 0.23 1.17 1.35 1.49 49
1980 0.75 0.01 0.69 0.75 0.82 49
Blood Lead (µg/dL)
1976-1980 13.99 6.12 10 13 17 10,049
1976 16.11 6.82 12 15 19 2,614
1977 14.2 6.18 10 13 17 2,287
1978 14.12 5.37 10 13 16 2,412
1979 11.87 5.03 8 11 14 2,412
1980 9.64 5.01 7 9 11 315
Notes: Gasoline Lead is national tetraethyl-lead (TEL) concentrations (g/gal), cal-
culated as weighted average across all gasoline grades; Blood lead is national aver-
age BLL (µg/dL) from NHANESII sample;
1976. As TEL concentrations declined over the phase out period, similar reductions in BLLs are
observed among the NHANESII respondents.
1.4 Results
1.4.1 Evidence of lead effects
The results of fitting Equation 1.4 using linear estimator and the NHANESII data set are pre-
sented in Table 1.3. The covariates used follow the same definitions of Reyes (2007, 2015), and are
the common set of predictors used in the empirical strategy of Chapters 2 and motivate the analysis
of Chapter 3.7 The dependent variable in Columns 1, 3, 5, and 7 is observed BLL (µg/dL), with
7As an additional validity test of the final state gasoline sales and TEL concentration time series data collected,
we reproduce the results of Reyes (2015). For reference, Appendix Table C.1 is the replication of Reyes (2015), Table
3. One caveat to note regarding the reconstruction of the data used in our analysis versus that of Reyes (2015) is the
time step of gasoline sales. The author was able to collect the complete set of gasoline sales records at the monthly
time step. However, available data sources limited our data to annual gasoline sales by grade. As such, we substitute
“Year” fixed effects for “Month” fixed effects to control for the seasonality of gasoline sales.
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Table 1.3: Average gasoline lead concentration (TEL) effect on blood lead, linear regressions
(1) (2) (3) (4) (5) (6) (7) (8)
Blood Lead ln(Blood Lead ) Blood Lead ln(Blood Lead ) Blood Lead ln(Blood Lead ) Blood Lead ln(Blood Lead )
Gasoline Lead (g/gal) 6.763*** 0.431*** 4.920*** 0.361***
(0.910) (0.051) (0.517) (0.041)
Reference (Gasoline Lead Q1)
Gasoline Lead Q2 2.009** 0.136*** 1.928*** 0.157***
(0.798) (0.045) (0.475) (0.040)
Gasoline Lead Q3 3.393*** 0.227*** 3.226*** 0.235***
(0.685) (0.036) (0.571) (0.046)
Gasoline Lead Q4 6.029*** 0.388*** 4.294*** 0.322***
(1.090) (0.062) (0.488) (0.039)
Age -0.313** -0.015* -0.318** -0.015* 0.041*** 0.003*** 0.041*** 0.003***
(0.139) (0.008) (0.140) (0.008) (0.010) (0.001) (0.010) (0.001)
Female -0.485** -0.031** -0.446** -0.029** -4.203*** -0.307*** -4.211*** -0.308***
(0.220) (0.014) (0.218) (0.014) (0.151) (0.011) (0.152) (0.011)
Black 5.326*** 0.301*** 5.344*** 0.302*** 2.566*** 0.188*** 2.636*** 0.193***
(0.487) (0.020) (0.486) (0.020) (0.305) (0.019) (0.294) (0.018)
Constant 1.364 1.703*** 8.789*** 2.168*** 4.861*** 1.841*** 8.947*** 2.135***
(1.706) (0.105) (1.367) (0.094) (0.835) (0.069) (0.531) (0.043)
Observations 2,430 2,430 2,430 2,430 9,148 9,148 9,148 9,148
R2 0.296 0.359 0.293 0.357 0.240 0.285 0.240 0.283
Ages 0-6 0-6 0-6 0-6 all all all all
Notes: Robust county clustered errors in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1; Blood lead is µg/dL; Gasoline Lead (TEL) is annual, state, average
tetraethyl-lead concentrations (g/gal), corresponding to year of laboratory examination and state of residence; Age is respondent’s age (years) at the time of
examination; Female=1 if respondent is female; Black=1 if respondent is African American;
the natural log of BLL used in the remaining columns. The predictor of interest is gasoline lead
concentrations. These values are calculated using Equation 1.4 and are annual, state average TEL
concentrations capturing the marginal effect of the CAA on the underlying lead exposure channel.
Regressions 1 to 4 of Table 1.3 are restricted to the sample of children under the age of seven
years old at the date of examination.8 Across each of the four specifications, gasoline lead is a
significant predictor of blood lead in children. The baseline regression in column one suggests that
a 1 g/gal reduction in TEL decreases BLL an estimated 6.8 µg/dL (95% CI: 4.9, 8.6). Recall, the
current BLL reference value for at risk children, defined by the CDC, is 5 µg/dL (CDC, 2019).
When the dependent variable is the natural log of blood lead as shown in Column 2, the results
remain highly statistically significant.
To further investigate the lead exposure channel, we convert the continuous TEL variable into
quartiles and include indicators for the quartile corresponding to the respondent’s state of residence
at the date of the blood draw. Column 3 shows the results of a linear-linear model when gasoline
lead quartiles are introduced. Relative to respondents in states in the first quartile, mean BLLs
are an estimated 2 µg/dL higher among those in the second quartile, and an estimated 3.4 and 6
µg/dL higher for those residing in the third and fourth quartiles respectively. Again, these results
are mirrored in the log-linear estimates of Column 4 and remain significant at the 99% confidence
level.
The results shown in Columns 5 to 8 fit the models used in Columns 1 to 4 on the full NHANE-
SII sample. When the inclusion criteria is relaxed, the estimated effect of changes to gasoline lead
on BLL is largely unchanged and remains highly statistically significant. The linear-linear esti-
mates in Column 5 suggest that a one g/gal reduction in TEL reduces mean BLL by an estimated
4.9 µg/dL (95% CI: 3.9, 6.0). Comparing the coefficient estimates in Column 1 and Column 5,
the underlying physiological factors which place children at greater health risks of lead exposure
relative to adults become clear. For example, age is a significant predictor of BLL in both models,
with the coefficient estimate for children in Column 1 being non-positive and comparatively large
8This inclusion criteria uses the NHANESII sub-sample of children, in which all children aged 6 months through
6 years old were selected for laboratory analysis.
22
Figure 1.8: Average gasoline lead concentration effect on blood lead
in magnitude relative to the estimate in Column 5. When indicators for gasoline lead quartiles are
included in Column 7, the coefficient estimates again reflect the positive, incremental increase in
estimated BLLs relative to the first quartile. Here, the estimated level effect on BLLs is an increase
of 1.9 and 3.2 µg/dL for those in the second and third quartiles respectively, and is relatively similar
to estimated impact on children shown in Column 3. For respondents living in states with gasoline
lead concentrations above the 75th percentile, the estimated increase in mean BLL relative to the
first quartile is 4.3 µg/dL.
The graphical representation of the dose responsiveness across both sample groups is illustrated
in Figure 1.8. Panel A shows the marginal effects using regressions shown in Columns 1 and 2 and
are restricted to the children subgroup. Panel B represents the full sample using Columns 5 and
6. Across the two sample groups, the marginal effect estimated across all ages is approximately
two thirds of the marginal effect when estimated on the subset of children. This is in line with
expectations as the dose responsiveness of BLL and age in children is non-linear with the largest
marginal effects occurring between one and three years of age, attributable to repeated hand-to-
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mouth behaviors and pica Mielke and Reagan (1998), as well as their physiology at this stage in
life (Needleman and Bellinger, 1991).
1.4.2 Test of identifying assumptions
To test the robustness of our identifying assumptions, we apply an indirect test of the gasoline
lead – blood lead exposure channel. Recall from Section 1.3.2, the lead exposure channel is proxied
for by TEL and corresponds to the state and year in which each BLL in the NHANESII data was
collected. Since the accurate matching of individual’s BLLs to state-year TEL values are essential
to the analysis above, we test our identification strategy by randomly assigning the gasoline lead
exposure channel.
For each individual i in our NHANESII sample, we construct the following data point for this
robustness test. Using the same notation as Equation 1.4, where j is i’s state of residence when his
blood is measured in year t. Let the set of states in the gasoline lead data set be J and the set of
years under observation be T . Then for i, a randomly drawn state j′ ∈ J and year t′ ∈ T , where
j′ 6= j and t′ 6= t, is used to assign a TEL value. Our robustness test estimates:
BLLijt = α + β1TELj′t′ + X
′
ijtβ + Γ2M t + Γ1Zt + Γ3Sj + ǫijt (1.5)
where all terms carry from Equation 1.4, and TELj′t′ is the randomly assigned state, year, TEL
concentration capturing the lead exposure channel. While it is plausible that the the findings pre-
sented above are simply coincidental, this strategy enforces randomness of the exposure mecha-
nism and indirectly tests the robustness of the gasoline lead effect on BLL. As such, the blood
lead – gasoline lead relationship should dissipate for a randomly assigned TEL, and β̂1 should be
indistinguishable from zero.
Using the same models of Table 1.3, the results of applying this strategy are shown in Table 1.4.
As expected, the estimated direct effect of gasoline lead concentrations on BLLs in both sample
groups is insignificant for both the linear-linear and log-linear models. Results are similarly in-
significant when gasoline lead is converted to quartiles and fit to the set of children (Columns 3, 4)
and the full sample (Columns 7, 8).
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Table 1.4: Falsification test of randomized average gasoline lead concentrations on lead exposure
(1) (2) (3) (4) (5) (6) (7) (8)
Blood Lead ln(Blood Lead ) Blood Lead ln(Blood Lead ) Blood Lead ln(Blood Lead ) Blood Lead ln(Blood Lead )
Gasoline Lead (g/gal) 0.427 0.018 -0.452 -0.032
(1.232) (0.067) (0.460) (0.034)
Reference (Gasoline Lead Q1)
Gasoline Lead Q2 -3.024* -0.163 0.176 0.030
(1.653) (0.098) (0.809) (0.059)
Gasoline Lead Q3 -0.188 0.004 -0.058 0.011
(1.778) (0.114) (0.924) (0.071)
Gasoline Lead Q4 -1.115 -0.071 -0.367 -0.018
(1.622) (0.091) (0.640) (0.047)
Age -0.293** -0.014* -0.294** -0.014* 0.042*** 0.003*** 0.042*** 0.003***
(0.143) (0.008) (0.140) (0.008) (0.010) (0.001) (0.010) (0.001)
Female -0.444* -0.028* -0.440* -0.029** -4.243*** -0.310*** -4.240*** -0.310***
(0.226) (0.014) (0.227) (0.014) (0.150) (0.011) (0.152) (0.011)
Black 5.421*** 0.307*** 5.461*** 0.310*** 2.725*** 0.200*** 2.718*** 0.199***
(0.498) (0.019) (0.451) (0.017) (0.261) (0.016) (0.252) (0.016)
Constant 10.673*** 2.304*** 11.833*** 2.354*** 12.289*** 2.385*** 11.970*** 2.349***
(1.371) (0.084) (1.715) (0.113) (0.521) (0.040) (0.885) (0.067)
Observations 2,430 2,430 2,430 2,430 9,148 9,148 9,148 9,148
R2 0.267 0.322 0.274 0.328 0.211 0.250 0.210 0.250
Ages 0-6 0-6 0-6 0-6 all all all all
Notes: Robust county clustered errors in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1; Blood lead is µg/dL; Gasoline Lead (TEL) is annual, state, average
tetraethyl-lead concentrations (g/gal), corresponding to year of laboratory examination and state of residence; Age is respondent’s age (years) at the time of
examination; Female=1 if respondent is female; Black=1 if respondent is African American;
Figure 1.9: Randomized gasoline lead concentration exposure risk on blood lead
The dose response curves estimated using this strategy are shown in Figure 1.9. Compared to
Figure 1.8, the marginal effects in Figure 1.9 are statistically insignificant. The randomization of
the lead exposure channel dissolves the significance of TEL on blood lead, yet the remaining set of
covariates are effectively unchanged with respect to the statistical significance of their coefficients.
Though this strategy is imperfect, it is included as divergent validity evidence in support of the
identifying assumptions underlying the empirical analysis presented above and in the chapters that
follow.
1.5 Discussion and conclusion
Exploiting the spatial and temporal variation in gasoline lead concentrations following the
Clean Air Act, we find considerable evidence supporting this flow source of environmental lead
as a significant vector of lead exposure among children and adults. Following the work of Reyes
(2007, 2015), we leverage the natural experiment created by the phase out of leaded gasoline to
identify and estimate the causal effect of reductions in the flow of environmental lead from auto-
mobile emissions to individual blood lead levels at the national level. As average gasoline lead
declined under the CAA, it produced quasi-random variations in lead emissions and in turn, re-
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sulted in heterogeneous lead exposure risk across states during the phase out. Using annual, state
averaged gasoline lead concentrations for the period 1976 to 1980, our results show a strong, posi-
tive relationship with individual blood lead levels among NHANESII survey respondents. Results
from sensitivity and robustness tests show this relationship remains highly statistically significant,
with the largest health benefits from the policy going to the youngest age groups. These findings
emphasize the success of this national policy with respect to improving public health by stem-
ming the flow of lead into the environment attributable to the consumption of leaded automobile
gasoline.
While the CAA is responsible for the removal of lead from gasoline, the stock of legacy lead
from this source, along with the flow of environmental lead from remaining source polluters con-
tinues to threaten public health. In the United States, flow sources of lead include point source
toxic release inventory facilities and aviation gasoline. As of 2017, a total of 4,155 facilities re-
ported on-site disposal or releases of lead to the Toxic Release Inventory (TRI) system of the EPA.
Combined, these facilities disposed or released 10,894,687 pounds of lead on-site at their facilities.
In addition, 3,809 facilities disposed or released just shy of 1 billion pounds (942,261,070) of lead
compounds on-site at their facilities in 2017.
In contrast to the incidents reported to the TRI system, the dispersion of atmospheric lead
extends far beyond the source. More than 50% of the current flow of atmospheric lead is from
the deposition of leaded aviation gasoline used by piston-engine aircraft. About 160,000 piston-
engine aircraft (PEA) are registered in the United States, constituting about 70% of the U.S. air
fleet. These aircraft consume over 200 million gallons of avgas annually (Kessler, 2013), implying
a flow of about a million pounds of lead each year.
Evidence of this can be found in the soil lead content across the U.S.. Soil samples drawn
from a number of rural and urban counties in the mid 1970’s and again in the early 2000’s were
found to have lead soil concentrations of 19.5 µg/kg and 21.11 µg/kg respectively (Clay et al.,
2018). Soil lead as a cause for health concern has been documented in many empirical studies
showing strong associations between neighborhood soil Pb, children’s blood Pb, and learning or
behavioral outcomes (Mielke and Reagan, 1998; Mielke et al., 2007; Johnson and Bretsch, 2002;
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Zahran et al., 2011). For the approximately 16 million people (and 3 million children) that live
within a kilometer of an airport that services piston-engine aircraft, the risk of lead exposure is
serious. In fact, studies find that child blood lead levels: increase dose-responsively in proximity
to airports, decline measurably among children sampled in the months after 9-11, resulting from
the restriction of the flight behavior of PEA, increase dose-responsively in the flow of PEA traffic,
and increase in the percent of prevailing wind days drifting in the direction of a child’s residential
location (Zahran et al., 2017b).
As national policies have eliminated the use of lead in paints and automobile gasoline, substan-
tial reductions to the flow of lead into the lived environment have been realized. Yet, both stock
and flow sources of exposure risk remain in the United States, presenting an ongoing health hazard
that is both ubiquitous and indiscriminate.
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Chapter 2
Childhood lead exposure, cognitive ability and risk
preferences in adulthood
2.1 Introduction
Lead (Pb) is a neurotoxicant with developmentally harmful effects in children. Many stud-
ies link lead exposure to adverse cognitive, behavioral and physical health outcomes in children
(Needleman and Bellinger, 1991; Dietrich et al., 2001; Canfield et al., 2003; Reyes, 2007; Jusko
et al., 2008; Nigg et al., 2010). Despite recent national interest in lead exposure following pre-
ventable failures in water distribution systems in Flint, Michigan and Newark, New Jersey, lead
pollution in the United States is generally regarded as a legacy problem. The enactment of various
national policies – like the Clean Air Act which resulted in the removal of lead from automotive
gasoline sold to consumers – effectively reduced the flow of lead (Pb) into the environment and
caused blood lead levels (BLLs) in children to decline dramatically (Raymond et al., 2014).
While lead has been effectively banned in United States from historic uses – as a constituent
in paint, plumbing, and automotive gasoline – scientists caution against the concept of lead as a
strictly historic or rear-view problem. Lead-formulated aviation gasoline (avgas) used in piston
engine aircraft remains an important source of new emissions. The flow of lead from avgas is
about a million pounds per year (Kessler, 2013). While small compared to the amount consumed
historically in automotive gasoline, the deposition of avgas remains a source of exposure risk to
the estimated three million children residing within one kilometer of airport facilities that service
piston engine aircraft (Zahran et al., 2017a).
An under-appreciated contemporary source of child lead exposure is lead-concentrated soils,
primarily due to legacy deposition from lead-formulated automotive gasoline. Scientists have con-
vincingly linked child BLLs to the accumulation of lead in residential soils. Contaminated soils en-
ter the body through ingestion (involving hand-to-mouth behaviors) or inhalation of re-suspended
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dust particles in summer months (Filippelli et al., 2005; Laidlaw et al., 2005, 2012; Zahran et al.,
2010, 2011, 2013). Another exposure pathway for children in the United States is dust associ-
ated with deteriorating or haphazardly removed lead-based paint, covering the interior and exterior
walls of older homes built before 1950 (when leaded paint was in widespread use).
Lead persists not only in the lived environment, but also in the human body. While the half-
life of lead in the human bloodstream is about thirty days (Papanikolaou et al., 2005), the metal
can persist in human tissue, the brain, and the skeletal system for many decades after an exposure
event, causing measurable failures in cardiovascular and renal systems as well as early onset of
neurodegenerative diseases in adulthood (Bellinger et al., 1987; Needleman and Bellinger, 1991;
Zahran et al., 2017b). To a growing cadre of economists and epidemiologists, the persistence of
the lead problem is evidenced in present-day intellectual and cognitive effects in adults exposed to
lead in early childhood. Numerous studies have found that elevated BLLs in young children are
associated with measurable reductions in intellectual ability (Bellinger, 2008, 2011, 2017; Clay
et al., 2019).
More preliminary, but economically meaningful, evidence suggests that the intellectual im-
pairments caused by early childhood lead exposure are lasting and possibly growing in age. In a
recently published study in the Journal of the American Medical Association involving more than
500 adults observed repeatedly over four decades, Reuben et al. (2017) report that adults raised
in the era of widespread leaded gasoline use experienced significant reductions in IQ and deficits
in perceptual reasoning and working memory. The higher the blood lead level in childhood, the
greater the loss in cognitive function and occupational status in adulthood.
A growing body of research also relates childhood lead exposure to abnormal behaviors in
adulthood. Bellinger (2008) finds children with prior acute lead exposure exhibit abnormal behav-
iors such as irritability, impatience, and aggression which persist after BLLs return to pre-exposure
levels. Economist Reyes (2015) has shown that persons exposed to lead in early life experience “an
unfolding series of adverse behavioral outcomes: behavior problems as a child, pregnancy and ag-
gression as a teen, and criminal behavior as a young adult.” Far from being a legacy problem, lead
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exposure appears to echo through the life-course, impairing the realization of health and human
capital among its many victims.
Studies using neural-imaging find that adults exposed to lead as children have reduced gray
matter in regions of the brain known to govern executive judgment and impulse control, cogni-
tive factors that are implicated in the expression of preferences both revealed and stated (Cecil
et al., 2008; Cecil, 2011). Behavioral scientists and economists have shown that judgment and
impulse control meaningfully underwrite economic and social preferences and behaviors that in-
volve risk and prospecting of uncertain futures (Thaler and Shefrin, 1981; Fudenberg and Levine,
2006; Khwaja et al., 2007). In this paper, we analyze whether lead exposure in childhood impacts
cognitive ability and the presence of abnormal latent preferences toward risk and uncertainty in
adulthood. To identify the causal relationship between BLLs in childhood and the realization of
lower cognitive ability and abnormal risk preferences in adulthood, we exploit the phase out of
lead from gasoline as an exogenous source of variation in lead emissions at a national scale.
Under the Clean Air Act (CAA), a timeline for the removal of lead from gasoline was im-
plemented beginning in 1975. Specifically, this policy would target the anti-knock lead additive
tetraethyl-lead (TEL), used to boost gasoline octane and improve engine performance (Needleman,
2000; Reyes, 2007). Over the following two decades, lead entering the environment from auto-
mobile emissions decreased precipitously. Though the policy was enacted at the national level,
specific characteristics relating to the petroleum and automobile industries caused meaningful vari-
ation in lead emissions across states between 1975 and 1990. Since lead emissions resulting from
the consumption of leaded gasoline was the most important source of lead exposure in children
over this period, we use variation in gasoline lead concentrations to capture this quasi-random
exposure channel.
This paper builds off existing literature that investigates the lasting health impacts of environ-
mental externalities. Our analysis finds strong evidence supporting the effect of childhood lead
exposure and later-in-life outcomes relating to both cognitive impairment and risk preferences.
Estimating the causal relationship across a series of tests, we find that blood lead levels in child-
hood are a significant predictor of: 1) IQ loss, measured with standardized test scores; 2) increased
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likelihood of low-IQ outcomes in exposure levels; and 3) increased abnormal risk response across
a series of situations involving uncertain outcomes. To test the robustness of the identification
strategy underlying our empirical analysis, we provide a divergent validity test in which the lead
independent outcome, individual’s dominant hand preference, is regressed on the childhood blood
lead exposure channel. Across an ensemble of evidence, our results illustrate the significance and
persistent effect of early in life lead exposure. These findings are a novel contribution to this area
of research for the causal effect of lead exposure which we is modeled.
Analyses detailed in the following sections attempt to answer whether quasi-random exposure
to lead in childhood produced significant cognitive and risk preference effects in adulthood. The
remainder of the chapter is structured as follows: Section 2.2 summarizes pertinent literature on
lead exposure as it relates to adverse health outcomes and abnormal psychology in adulthood.
A discussion of the data used and empirical strategy used to identify the causal effects of lead
exposure is found in Section 2.3, followed by results in Section 2.4. Finally, the chapter closes
with a discussion and conclusion in Section 2.5.
2.2 Literature review
Unlike iron and magnesium, lead is not an essential element to the human body. While the
symptoms of lead poisoning typically occur at high levels of lead exposure, any quantity entering
the body along the extensive margin is effectively toxic (Bellinger and Bellinger, 2006). Both the
Environmental Protection Agency and the Centers for Disease Control have stated that there is no
known safe level of lead exposure (DHHS 2012; CDC 2012a, 2012b).
Although lead is a naturally occurring metal, legacy anthropogenic sources such as deterio-
rating lead-based paint in aging homes (Farfel et al., 2005b), as well as emissions from leaded
gasoline (Needleman, 2000; Filippelli et al., 2005; Gould, 2009; Kessler, 2013) have posed more
substantial risk to public health (Needleman and Bellinger, 1991; Filippelli et al., 2005; Abadin
et al., 2007; Reyes, 2007). Exposure to these legacy sources of lead are typically in the form of
lead dust. This dust can create a residue on foods prior to consumption (Abadin et al., 2007). Lead
dust also mixes with topsoil, and researchers have found large, positive correlations between soil-
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lead concentrations and blood lead levels (BLLs) in a given area (Reagan and Silbergeld, 1989;
Johnson and Bretsch, 2002; Mielke et al., 2005; Laidlaw and Filippelli, 2008; Laidlaw et al., 2012;
Filippelli and Laidlaw, 2010). This relationship between child BLLs and neighborhood soil lead
accumulation is likely causal (Zahran et al., 2010; Clay et al., 2019).
In their review of existing literature comparing the two legacy sources of lead – paint versus
soil - Mielke and Reagan (1998) note that “exposure to lead-contaminated soil, house lead dust, or
street dust has consistently shown a positive correlation to blood lead and population blood lead
levels.” Inhalation of lead-laced dust has been shown to occur when particles are re-suspended
during dry summer months or weather related events (Laidlaw et al., 2005, 2012; Filippelli et al.,
2005; Zahran et al., 2013). Due to this phenomenon, the rate of uptake can vary significantly for
children compared to adults, as children’s higher rate of hand-to-mouth activities place them at
greater risk of lead entering their bodies relative to other age groups (Mielke and Reagan, 1998;
Nilsson, 2009).
The negative impacts of lead exposure on a child’s cognitive development has long been rec-
ognized by the medical profession. Reports published by the EPA show that the estimated dose-
response curve for lead exposure with respect to cognitive and behavioral effects in children are
non-linear, with larger marginal effects at lower blood lead levels. These findings are echoed
in a number of other studies which emphasize the marginal impact of increases in child BLLs
along the intensive margins on IQ loss, school performance, and neuro-psychological impairments
(Bellinger et al., 1987; Needleman and Bellinger, 1991; Lanphear et al., 2005; Bellinger, 2008).
These findings have been replicated in other countries as well. In his analysis of lead exposure and
cognitive development in Swedish children, Nilsson (2009) confirms the significance of the current
reference threshold of 5 µg/dL, defined by the U.S. Center for Disease Control as a benchmark of
concern (Needleman, 2004; Toscano and Guilarte, 2005; Bellinger and Bellinger, 2006).
Studies have shown that lead exposure in childhood impacts cognition and the realization of
abnormal behaviors into adolescence. Aizer and Currie (2017) find that childhood lead exposure
results in higher incidents of juvenile delinquency in adolescence. Reyes (2015) finds that child-
hood lead exposure is a significant predictor of risky behaviors in adolescence, including excessive
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drinking and smoking and the risk of teen pregnancy. Recently, researchers have estimated the
causal effects of childhood lead exposure on outcomes in adulthood, including fertility behavior
and deleterious birth outcomes (Clay et al., 2018), violent crime (Nilsson, 2009; Curci and Masera,
2017; Mielke and Zahran, 2012), neurodegenerative diseases (Zahran et al., 2017a), and a series of
abnormal behaviors in young adulthood (Graff Zivin and Neidell, 2013). Perhaps most compelling,
Reuben et al. (2017) find that adult New Zealanders exposed to lead in childhood had measurable
reductions in IQ and occupational status in midlife, with these negative effects of early childhood
exposure amplifying over the life-course.
Providing a neurological basis for these observed effects of abnormal psychology and behavior,
Cecil et al. (2008) find a strong, inverse dose response relationship between mean childhood blood
lead levels and brain volume in adults. Using magnetic resonance imaging to measure brain matter
in individuals born between 1979 to 1984, the authors find statistically significant losses in the
structural volume of the brain, specifically in the prefrontal cortex that is considered the seat of
decision making and impulse control in the brain. Moreover, Froehlich et al. (2007) show that lead
impacts a set of genes controlling dopamine receptors that are associated with executive judgment,
providing a plausible underlying biochemistry for the abnormal psychology of adults lead exposed
as children.
Taken together, the research literature shows that childhood lead exposure significantly im-
pairs the cognitive and socio-emotional development of children, with these impairments persisting
through the life-course and manifesting in abnormal psychology and behavior. Insofar as exoge-
nous exposure to lead in childhood compromises decision making and mood regulation, one might
also expect to see cognitive effects and abnormalities in economically meaningful behavior in-
volving the prospecting of risk and uncertainty in adulthood. In the next section, we describe our
econometric strategy for evaluating cognitive effects and the presence of abnormal preferences in
adults randomly exposed to lead in childhood.
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2.3 Methods
2.3.1 Data and measurement
National Longitudinal Survey of Youth
The primary data set used in the analysis is from the National Longitudinal Survey of Youth
(NLSY), sponsored and directed by the U.S. Bureau of Labor Statistics (BLS) and and managed by
the Center for Human Resource Research (CHRR). The purpose of this survey is to track outcomes
relating to transitions in and out of the labor force at various of stages of life (CHRR, 2019).
Although the BLS has administered this survey to several cohorts, our analysis relies on data from
the survey following individuals born between 1980-1984. Respondents from this cohort were first
interviewed in 1997 (NLSY97), corresponding with the timing of the youngest respondents in the
sample entering the labor force.
To create a nationally representative sample, the NLSY97 is constructed using a complex sur-
vey design.9 Given the stated goal of the survey, the bulk of the data collected speak to employment
outcomes, labor market conditions, and human capital investments. Complementing these data is
a base set of demographic and socioeconomic variables on each respondent, as well as an inven-
tory of family and household characteristics during the respondent’s youth, physical and mental
health assessments, and a complete geographic history of migration and places of residence.10 In
the analyses that follow, many control variables are used, including respondent’s sex, racial status,
age in years, and a set of indicator variables for household income to Federal Poverty Level (FPL)
quartiles.11 Table 2.1 reports descriptive statistics on demographic and socioeconomic variables
for the 1980-1984 cohort, divided by cross-sectional and supplemental NLSY97 samples.
9To satisfy the survey design requirement and provide sufficient sample size for statistical analysis of minority
groups, the NLSY97 cohort is comprised of two sample groups: a “cross-sectional” sample and an “oversample” of
black and Hispanic or Latino respondents (CHRR, 2019).
10The geographic data is provided by the BLS for research purposes and is not available in the public data files
to maintain respondent confidentiality. The non-public geographic data identifies each respondent’s place of birth,
migration history, and place of residency down to the county level for each survey round.
11The household income to poverty level data is generated by the BLS. Values are for the previous year and adjusted
for household size (CHRR, 2019).
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Table 2.1: Descriptive statistics, NLSY97
Cross Sectional Sample Supplemental Sample
Mean Std. Dev. Mean Std. Dev.
Survey Round 1 (1997)
Birth Year 1982 1.39 1982 1.39
Sex 51% 0.50 51% 0.50
White 74% 0.44 0% 0
Black 17% 0.37 75% 0.43
Hispanic 8% 0.27 25% 0.43
Teen Pregnancy 24% 0.43 40% 0.49
HS Graduate (Mother) 84% 0.37 71% 0.45
HS Graduate (Father) 83% 0.38 71% 0.45
Low Income Group 34% 0.47 67% 0.47
Middle Income Group 22% 0.42 25% 0.36
HH Income to Poverty Ratio 318 277.02 175 181.61
Survey Rounds 14,15 (2010, 2011)
Age 28 1.45 28 1.45
Married 37% 0.48 21% 0.41
HS Graduate 82% 0.39 70% 0.46
College Graduate 29% 0.45 15% 0.36
HH Income to Poverty Ratio 370 335.83 230 273.37
Sample Size 3,838 998
Notes: Labels with Mother (Father) are biological mother (father); Indicators are de-
fined as: Sex=1 for male, Teen Pregnancy=1 if the respondent’s biological mother was
a teenager at respondent’s time of birth; HS (College) Graduate are indicators for edu-
cational attainment, 1 = high school (4 year college) degree, 0 o.w.; Income groups are
household income relative to Federal Poverty Level (FPL), defined as: Low=1 for < 2x
FPL and Mid=1 for ratios ≤2x FPL and <3x FPL;
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Risk preference and cognitive ability data
In addition to demographic and socioeconomic variables, the NLSY97 has data on survey ques-
tions pertaining to a respondent’s self-reported appetite for risk as well as measures of intelligence
based on results from standardized achievement tests. With respect to an individual’s risk pref-
erences, the NLSY97 has a set of questions measuring an individual’s willingness to accept risk
in various circumstances. Respondents are asked to rate their willingness to accept risk generally
and across a series of contexts pertaining to a respondent’s health, finances, romantic relationships,
driving behavior, gambling and work life, among other domains of risk taking. The most general
question, asked first in the NLSY97, reads:
Are you generally a person who is fully prepared to take risks or do you try to avoid
taking risks? Rate yourself from 0 to 10, where 0 means “unwilling to take any risks”
and 10 means “fully prepared to take risks.”
The same response categories of 0 meaning “unwilling to take any risks” and 10 meaning “fully
prepared to take risks” obtain for the more specific domains of risk-taking in health, finances, work
and so on. The complete question set is detailed in Appendix Section A.
Taking direction from abnormal psychology, we calculate the degree to which an individual’s
response to each risk preference question deviates from the norm. Under this definition of abnor-
mality, a respondent’s appetite for risk is deemed abnormal if her answers are statistically deviant.
Assuming the sample mean is representative of normal risk preferences, the distance between the
mean and the stated preference of the respondent is indicative of abnormality.
Let Z be the set of survey questions describing a respondent’s appetite for risk, then the stated
preference for individual i is zi for z ∈ Z. Then, defining the sample mean for z as z,
12 we
calculate mean deviation among NLSY97 respondents as:
yzi = ln(|zi − z|) (2.1)
12Sample means are calculated using inverse probability weights, adjusted for the NLSY97 survey design.
37
where yzi is the outcome of interest, measuring the relative deviation from central tendency for
each risk question z ∈ Z.
With respect to outcomes relating to general intelligence, we use exam scores for each respon-
dent collected during round one of the survey (1997). The BLS administered a modified version
of the Armed Services Vocational and Aptitude Battery (ASVAB) examination to all respondents
in the NLSY97 sample. The values are reported as percentile scores mapping closely to IQ per-
centiles in similar tests, such as the SAT and ACT.
National Health and Exercise Survey blood lead data
Blood lead data are from the Second National Health and Exercise Survey (NHANESII), pro-
vided by the Centers for Disease Control (CDC). This nationally representative survey was in-
tended to provide a detailed description of the overall health of the nation (NCHS, 1982). Ap-
proximately 20,000 individuals, aged 6 months to 74 years old, were surveyed between February
1976 and February 1980. Demographic, socioeconomic, employment and household characteris-
tics were collected alongside full biochemistry and physiological analyses to deliver a comprehen-
sive description of American health at the time.
A subset of respondents were selected for laboratory analysis of blood composition, which
measured the presence of heavy metals known to be toxic, including lead. The selection criteria
for laboratory analysis included all children between six months and six years old, along with
half of the remaining sample aged 7 to 74 years old chosen at random (NCHS, 1982). In all, the
sub-sample included blood lead data for 10,049 individuals reported in units of micro-grams-per-
deciliter (µg/dL) of blood.
The NLSY97 data set does not include respondent blood lead data, therefore we must rely on
the blood lead samples collected from the NHANESII survey respondents. To estimate BLLs for
NLSY97 respondents we restrict to a set of regressors present in both NHANESII and NLSY97
data sets. Since the two surveys were conducted by different institutions, variation in definitions
used for many common variables constrains the set of regressors which can be included in the
model. Moreover, the NLSY97 survey incorporates geographic definitions used in the 1980 de-
cennial census that was conducted after the NHANESII survey was fielded. The model selection
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criteria for stage 1 was therefore based on best statistical fit of blood lead outcomes given the set
of covariates available across both the NHANESII and NLSY97 data sets. Given this objective
and constraint, the final model specification used for stage two is a log-log model of blood lead
and gasoline lead relationship. Results of this strategy are presented in the next section, and a
replication of Table 3 from Reyes’s (2015) process for this cross-date set exercise can be found in
Appendix Table C.1.
Gasoline lead data
To reconstruct a time series of gasoline lead (TEL) concentrations at the state level, we follow
the methodology detailed in Reyes (2007, 2015). Utilizing petroleum industry records and govern-
ment publications, we construct the variable of interest TEL, as a weighted average of gasoline
sales and TEL concentrations. To capture the year-over-year effect of the CAA on the flow of
lead entering the environment from gasoline consumption, we produce a time-series of TEL for
each state and year using both gasoline sales volumes and TEL concentrations for each grade of
gasoline sold to consumers during the phase out.
To construct this metric, we first calculate total gasoline sales (Qjt) for state j in year t, by sum-
ming the total sales of each grade sold. During the phase out, gasoline was sold to consumers in
four grades: premium (p), regular (r), premium-unleaded (pu), and regular-unleaded (ru). Defin-
ing the set of gasoline grades as G = {p, r, pu, ru} and letting total sales for each grade g ∈ G, be
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weights, we calculate TELjt as the sum of concentration times the share of total sales, for each
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This calculation is performed for all states13 and each year over the period of interest. A more de-
tailed description of the data sources and this calculation are presented in Chapter 1, Section 1.3.1.
Recall from Chapter 1, to achieve the goal of phasing out leaded gasoline, the CAA set limits on
average TEL concentrations across all grades produced at a given production facility (Needleman,
2000). As such, the policy created an incentive for producers to make the costly investments
required to increase production of unleaded gasoline over the course of the phase out. Since the
CAA directly targeted gasoline lead concentrations, impacts of the policy were immediate and
distinct in the rate of reduction in TEL concentrations over time and across states. Take Figure 2.1
for example, which graphs the difference between national TEL and state level TEL for both the
NHANESII years (1975-1980) and the NLSY97 years (1981-1985). The downward trend in TEL
is evident in the deviation from the national average in the NLSY97 period versus the NHANESII
period across states, as all gasoline lead concentrations eventually converge to zero. Furthermore,
Figure 2.1 illustrates the extent to which the design and enforcement of the CAA induced quasi-
random inter-state variations in TEL across both time periods.
2.3.2 Empirical model
To test the hypothesis that childhood lead exposure impacts cognitive ability and risk prefer-
ences in adulthood, we apply the methodology of Reyes (2015) of a split sample two-stage least
13Due to data limitations, Alaska, Washington D.C., and Hawaii are excluded from our analysis.
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squares approach. This approach allows us to estimate the degree to which childhood blood lead
levels explain cognitive outcomes in adulthood. A stylized representation of this relationship is
shown in Equation 2.5.
Figure 2.1: State average gasoline lead (TEL) relative to national average, 1976-1985
The dependent variable, in this case, is the degree to which an individual’s response to risk
deviates from the norm, defined in Equation 2.1. The predictor of interest is blood lead level
(BLL), constituting our bio-marker proxying for childhood lead exposure. To estimate the causal
impact of childhood lead exposure on later in life outcomes, we rely on the state of residence
during childhood as the geographic feature linking variation in lead emissions to exposure. Recall,
the design of the CAA resulted in quasi-random variation in lead entering the environment as a
function of gasoline lead concentrations that varied across states over each year during the phase
out. Letting the state of residence during childhood be s, then for each individual i, BLLis is blood
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lead averaged over ages 12 to 36 months of a child’s life. The remaining explanatory variables and
the dependent variable correspond to adulthood, which we define as period t, corresponding to the
years in which the data underlying the outcome Y was collected.14
Defining Yijt as an outcome capturing individual i’s IQ or appetite for risk in year t and state
of residence j as a function of childhood lead exposure, the relationship of interest is expressed as:
Yijt = α + β1BLLis + X
′
ijtβ + Γ1Rj + Γ2Zt + ǫijt (2.5)
where, X ijt is a vector of covariates controlling for demographic, socioeconomic, and heritable
traits specific to the individual. Fixed effects for the state of residence and survey year are Rj , and
Zt respectively.
The coefficient of interest in Equation 2.5 is β1, capturing the expected marginal effect of a
change in childhood lead exposure on a later in life outcome Y . Since BLL is an indicator of
the underlying childhood lead exposure channel, a non-zero β̂1 which is statistically significant
supports the hypothesis that childhood lead exposure can partly explain abnormal risk preferences
in adulthood.
The first stage regression is described by Equation 2.6. Reductions in lead emissions following
the regulations imposed by the CAA are captured in the variable TELjs, corresponding to the
average gasoline lead concentration in state j and year s over the period in which NHANESII was
conducted.15 Then, using blood lead levels (BLLijs) as a measure of individual i’s lead exposure,
the affect of regulations on the lead exposure channel is modeled as:
BLLijs = α + γTELjs + Y is
′θ + ǫijs (2.6)
where the vector Y is includes controls for age, sex, race, and household income.
16
14For IQ outcomes, t is corresponds to round 1 (1997). For abnormal risk outcomes, t corresponds to rounds 14
and 15 (2010, 2011).
15The use of year subscript s is to re-enforce the time period across both surveys. NHANESII is conducted over
the years 1976 to 1980, and all respondents in the NLSY97 sample are born between 1980 and 1984.
16Respondent’s age is in years; sex (Female) and racial status (Black) are measured dichotomously, where Fe-
male=1 if non-male and Black=1 if black; indicator variables for household income are defined following Reyes
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The coefficient estimates obtained from fitting Equation 2.6 with the NHANESII sample are
then used to predict BLL’s in the NLSY97 sample. Using the same set of regressors, blood lead
is predicted for each respondent in the NLSY97 sample.
B̂LLijs = α̂ + γ̂TELjs + Y is
′θ̂ (2.7)
Substituting B̂LLijs from Equation 2.7 into Equation 2.5 produces the final specification for our
analysis:
Yijt = α + β1B̂LLijs + X ijt
′β + Γ1Rj + Γ2Zt + ǫijt (2.8)
The aim of our approach is to estimate the BLL effects of lead exposure, which is widely
recognized as a reliable measure of recent lead exposure risk across the academic literature.17
In defense of the identification strategy described in Section 2.2, our approach facilitates analy-
sis at a national scale and over a period of time in which the risk of lead exposure varied as a direct
result of an exogenous policy shock. The primary data sources are large, nationally representative,
surveys, with approximately 2,400 observations of children with BLLs in the NHANESII data and
approximately 4,500 respondents from NLSY97 satisfying the inclusion criteria to predict their
BLL. Furthermore, respondents in the NLSY97 sample were born in the years immediately fol-
lowing the period in which the NHANESII was conducted. The NHANESII survey was conducted
1976 to 1980 and the cohort selected for the NLSY97 was born between 1980 to 1984, with the
first interview taking place in 1997. Moreover, this time period coincides with the implementa-
tion and enforcement of the CAA, spanning the years in which the majority of TEL reductions
took place, implying dramatic reductions in the risk of lead exposure attributable to automobile
emissions. Given the NHANESII survey preceded the birth of NLSY97 respondents, coupled with
(2015) and derived from household income relative to Federal Poverty Line (FPL), where Low=1 for household in-
come < 2× FPL and Mid=1 for household income ∈ [2× FPL, 3× FPL);
17To account for the short-term nature of this lead exposure metric, we apply a similar strategy to that of Reyes
(2015) and estimate each respondent’s blood lead for each month between ages one and three (age 12-36 months) for
each respondent in the NLSY97 sample. we then take the two year centered average of estimated monthly blood lead
to reflect the body burden associated with persistent exposure in early childhood.
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Figure 2.2: US average blood lead and gasoline lead (TEL) concentrations, 1976-1985
the year-over-year reductions in lead exposure from falling TEL concentrations, predicted BLLs
among NLSY97 respondents should underestimate the true lead exposure risk during this period.
This implies any negative effects of lead exposure on the response variables are likely underesti-
mates using this empirical strategy. Take Figure 2.2 for example, which graphs the annual trends
of national TEL and BLLs over the phase out. At the national level, average concentrations de-
creased steadily over a ten-year period beginning in 1976. The vertical line in Figure 2.2 separates
the NHANESII data on the left, from the NLSY data on the right. The downward trend observed
in TEL is mirrored by national average BLLs among NHANESII respondents, as well as the
predicted values among NLSY97 respondents.
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2.4 Results
2.4.1 Evidence of gasoline lead effects
Results from the first stage regressions in which Equation 2.6 is fit using a linear estimator and
the NHANESII data are shown in Table 2.2. Observations are restricted to children aged six years
and under at the date of examination.18 The predictor of interest is average, annual state gasoline
lead concentrations TEL from Equation 2.4. Control variables are included for respondent’s sex
(Female), racial status (Black), and Age in years. Indicator variables for household income are
constructed following the definitions of Reyes (2015) and are household income relative to the
Federal Poverty Level (FPL), where Low=1 for household income < 2 × FPL and Mid=1 for
household income ∈ [2× FPL, 3× FPL). The dependent variable in Table 2.2 is BLL (µg/dL) or
natural log of BLL where noted.
Across each of the seven specifications, TEL is a significant predictor of blood lead in children.
Column 1 is the most sparse model, where child BLLs are regressed on TEL and month fixed
effects. The estimated effect of a 1 g/gal reduction in TEL decreases BLL by 3.9 µg/dL (95% CI:
1.44, 6.50). The estimated marginal effect of gasoline lead concentration remains highly significant
when state and year fixed effects are introduced in Column 2. The linear-linear specification in
Column 2 highlights the impact of the geographic and temporal variation as the addition of year
and state controls remove significance from the constant term, while the estimated effect of TEL is
more than double that of the spare model in Column 1 (estimated marginal effect of 9.4). Column 3
is the fully saturated model reflecting Equation 2.6, with an estimated 8.1 µg/dL reduction in blood
lead for a 1 g/gal decrease in TEL concentration (95% CI: 1.03, 15.14). As expected, age, racial
status, and low income group are highly statistically significant correlates of child BLLs, and in the
direction compatible with previous research (Campanella and Mielke, 2008). The results suggests
that mean BLLs are an estimated 5 µg/dL higher for Blacks relative to Whites and Hispanics,
and those in the Low income group (less than 2 times the Federal Poverty Level) have BLLs an
estimated 1.9 µg/dL higher relative to those in the highest income group.
18This inclusion criteria is motivated by the sampling design of the NHANESII survey, in which all children in this
age group were selected for laboratory analysis.
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Table 2.2: Blood lead effect of gasoline lead (TEL) concentrations, linear regressions (NHANESII)
(1) (2) (3) (4) (5) (6) (7)
Blood Pb Blood Pb Blood Pb ln(Blood Pb) ln(Blood Pb) Blood Pb Blood Pb
Gasoline Lead (g/gal) 3.966*** 9.390** 8.085** 0.630** 0.567** 7.887** 8.280**
(1.257) (4.354) (3.506) (0.278) (0.236) (3.505) (3.774)
Age -0.495*** -0.023*** -0.495*** -0.536***
(0.140) (0.007) (0.141) (0.140)
Female -0.445* -0.029* -0.433*
(0.234) (0.015) (0.246)
Black 5.151*** 0.288*** 5.149***
(0.502) (0.021) (0.496)
Low 1.912*** 0.110*** 1.922*** 2.465***
(0.316) (0.021) (0.317) (0.363)
Mid -0.103 -0.012 -0.085 -0.318
(0.425) (0.026) (0.428) (0.397)
Constant 8.094*** -1.083 0.860 1.471** 1.547*** 1.048 2.258
(2.310) (8.815) (7.164) (0.557) (0.472) (7.158) (7.656)
Observations 2,430 2,430 2,430 2,430 2,430 2,430 2,430
R2 0.086 0.192 0.301 0.260 0.368 0.301 0.243
State FE No Yes Yes Yes Yes Yes Yes
Year FE No Yes Yes Yes Yes Yes Yes
Month FE Yes Yes Yes Yes Yes Yes Yes
Ages 0-6 0-6 0-6 0-6 0-6 0-6 0-6
Notes: Blood lead is µg/dL; Robust state clustered errors in parentheses *** p < 0.01, ** p < 0.05, * p <
0.1; Gasoline lead is annual, state, averaged TEL (g/gal); Age is respondent’s age in years when survey was
conducted; Indicators for sex and racial status are defined as Female=1 and Black=1 if the respondent identifies
as African American; Indicators for household income relative to Federal Poverty Level (FPL) are: Low=1 for
< 2x FPL and Mid=1 for ratios ≤2x FPL to <3x FPL; State of residence, and Year and Month of survey fixed
effects are included in regressions;
The remaining columns in Table 2.2 are included as sensitivity and robustness tests. Columns 4
and 5 substitute the dependent variable with the natural log of blood lead. In both cases, the results
are largely unchanged with gasoline lead remaining statistically significant at the 95% confidence
level. Similarly, coefficient estimates for Age, Black, and Low income remain highly statistically
significant at the 99% confidence level. The fully saturated log-linear specification shown in Col-
umn 5 is the model used to predict BLLs for the NLSY97 respondents.
Lastly, sensitivity tests are included in Columns 6 and 7 using the linear-linear model from
Column 3.19 Removing the indicator for respondent sex in Column 6 reduces the coefficient es-
timate to a 7.8 µg/dL reduction in BLLs given a one unit decrease in gasoline lead, yet remains
highly significant. Similarly, removal of the race indicator variable Black returns a slightly higher
estimated marginal effect of gasoline lead on blood lead, suggesting a 1 g/gal reduction in gasoline
lead reduces BLLs by 8.2 µg/dL and is significant at the 95% confidence level.
Figure 2.3: US average predicted blood lead kernel density
19We have chosen to include results of sensitivity tests using the linear-linear model over the log-linear model for
ease of interpretation. Using the log-linear specification shown in Table 2.2, Columns 4 and 5 for this exercise returns
results which are effectively identical.
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Figure 2.3 plots kernel density estimates of BLLs by year of birth for the NLSY97 sample.
Here, BLLs are the predicted values using the log-linear specification from Table 2.2, Column
5.The reductions in gasoline lead emissions during this period are evident in the behavior of uni-
form shifts in BLLs among the NLSY97 respondents. As TEL falls in time, BLLs follow a similar
pattern as mean BLL decreases with each successive birth year. Similarly, Figure 2.3 shows the
the year-over-year density distributions becoming more Leptokurtic as the right skew diminishes
in mean BLLs across birth year cohorts. Descriptive statistics on NLSY97 predicted BLL are
included in Table 2.3.
Table 2.3 reports descriptive statistics on NLSY97 cognitive outcomes and risk preference vari-
ables for the 1980-1984 cohort, as well as description of these outcomes across early childhood
blood lead level quintiles. IQ is measured by respondents scores on the Armed Services Vocational
Aptitude Battery (ASVAB) examination. All NLSY97 respondents were administered the exami-
nation in round one of the survey, and is used as a proxy for cognitive intelligence. The ASVAB
has been shown to be highly correlated with other accepted standardized achievement tests, such
as the SAT and ACT exams (Koenig et al., 2008). Of particular interest in Table 2.3 is the be-
havior of IQ percentile and Low-IQ across child blood lead quantiles. IQ percentile decreases
dose-responsively across blood lead quantiles, from 57 (Q1) to 55 (Q2) to 50 (Q3) to 46 (Q4) and
to 34 (Q5). Intuitively, the fraction of sampled adults scoring below the 25th percentile on the
ASVAB exam increases dose-responsively in child blood lead quantiles.
Results in Table 2.4 extend the descriptive associations in Table 2.3, showing OLS models of
adult percentile score on the ASVAB exam regressed on child blood lead and control variables. The
predictor of interest is blood lead (µg/dL), which is the average predicted blood lead between 12 to
36 months old. Controls for respondent’s sex (Sex), racial status (Minority) and fixed effects for
survey sample group are included in all regressions.20 State of residence and birth year cohort fixed
effects are included where noted. Given prior literature showing a negative association childhood
20Indicators are Sex=1 for male and zero otherwise; Minority=1 for non-white racial status and zero otherwise;
Sample group fixed effect is based on NLSY97 survey design and is an indicator with a value of 1 for respondents in
the Cross Sectional Sample and 0 otherwise (e.g. respondent is classified as Supplemental Sample);
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Table 2.3: Descriptive statistics - IQ and risk preferences
Blood Lead Quintiles
Mean Q1 Q2 Q3 Q4 Q5
Blood Lead (µg/dL) 8.88 6.53 7.51 8.27 9.18 11.36
Gasoline Lead (g/gal, ages: 0-36 m.) 0.50 0.43 0.48 0.50 0.49 0.55
IQ Percentile 47 57 55 50 46 34
Low-IQ (< 25th Percentile) 31% 17% 20% 26% 33% 51%
Left Handed (throwing) 8% 7% 7% 9% 7% 9%
Right Handed (writing) 89% 90% 91% 88% 89% 88%










Sample Size 4,836 823 851 865 927 1,370
Notes: Blood lead is predicted blood lead (µg/dL); IQ Percentile is based
on ASVAB examination scores; Low-IQ is an indicator for exam scores at
or below the 25th percentile; Survey questions are abnormal response values




Table 2.4: IQ effect of blood lead, linear regressions
(1) (2) (3) (4) (5) (6) (7)
Blood Lead (µg/dL) -0.018*** -0.021*** -0.052*** -0.027*** -0.027*** -0.028*** -0.045***
(0.005) (0.006) (0.005) (0.005) (0.006) (0.005) (0.005)
Sex -0.023** -0.022** -0.021** -0.027*** -0.016 -0.023**
(0.009) (0.009) (0.009) (0.009) (0.009) (0.009)
Minority -0.173*** -0.167*** -0.081*** -0.092*** -0.054** -0.089***
(0.023) (0.025) (0.019) (0.019) (0.022) (0.019)
Poverty Ratio (Q1 Reference Group)
Poverty Ratio Q2 0.067*** 0.013 0.065*** 0.062***
(0.017) (0.019) (0.017) (0.017)
Poverty Ratio Q3 0.130*** 0.030** 0.128*** 0.122***
(0.011) (0.015) (0.011) (0.013)
Poverty Ratio Q4 0.194*** 0.015 0.192*** 0.190***
(0.016) (0.016) (0.016) (0.016)
Endowment 0.092***
(0.003)
Constant 0.654*** 0.697*** 0.931*** 0.624*** 0.692*** 0.626*** 0.722***
(0.040) (0.051) (0.044) (0.045) (0.053) (0.045) (0.053)
Observations 4,587 4,587 4,587 4,587 3,219 4,587 4,587
R2 0.182 0.184 0.232 0.278 0.417 0.276 0.270
State FE No No Yes Yes Yes Yes Yes
Cohort FE No Yes Yes Yes Yes Yes Yes
Oversample FE Yes Yes Yes Yes Yes Yes Yes
Notes: Dependent variable is percentile score on ASVAB examination; Robust state clustered errors in parentheses ***
p < 0.01, ** p < 0.05, * p < 0.1; Blood lead is predicted mean blood lead in µg/dL; Poverty ratio quartiles are based on
household income to poverty ratio, 1997 (survey round one); Endowment is the first principle component among mother’s
age at respondent’s time of birth, and years of education for the respondent and biological mother and father; State of
residence, over-sample group and cohort fixed effects included where noted;
lead exposure and cognitive IQ, the expectation for results in Table 2.4 is a negative coefficient
estimate for blood lead.
In the spare model shown in Column 1, the coefficient estimate for blood lead suggests a
1 µg/dL increase in childhood blood lead reduces IQ by 1.8 percentile points (95% CI: -0.027,
-0.008). Column 2 includes fixed effects for respondent’s year of birth (Cohort FE) and Column
3 introduces state of residence fixed effects.21 Controls for exogenous variation in access to and
quality of education, are included in the remaining columns of Table 2.4 and analytical emphasis
is placed on Column 4. A set of indicators for household income to Federal Poverty Level ra-
tio, by quartiles are introduced in Column 4. With the introduction of socio-economic controls,
the predicted marginal effect in Column 4 amplifies, with a unit increase in child BLL inducing
a 2.7 percentile point reduction in IQ scores in young adulthood (95% CI: -0.036, -0.017). As
expected, the coefficient estimates attached to poverty ratio quartiles (Poverty Ratio) are highly
significant and positively correlated with IQ. Relative to respondents in the lowest income quartile
(Q1), those in the second quartile score an estimated 6.7 percentile points higher on the ASVAB
examination, all else equal. Similarly, those in the third and fourth quartiles score an estimated 13
and 19 percentile points higher than their counterparts in the lowest income quartile respectively.
To place the estimated effect of blood lead on IQ into context, consider the difference in blood lead
concentrations shown in Table 2.3 between those in the lowest (Q1) and highest (Q5) quintiles.
Applying the coefficient estimate from Column 4 to the difference in average blood lead concen-
trations, we find an estimated differential of 13 IQ percentile points between individuals in the
highest exposure group, Q5 (11.36 µg/dL) to those in Q1 (6.53 µg/dL). This is comparable to the
estimated effect of socio-economic status between individuals in Q3 relative to their counterparts
in the lowest socio-economic group Q1.
The fully saturated model shown in Column 5 adds a composite variable Endowment to
capture the factors potentially impacting educational outcomes and performance on standardized
21State of residence is defined as the state in which the respondent was living when the survey round was conducted.
Data for outcomes relating to IQ were collected during round 1 (1997), and state fixed effects included in results of
Table 2.4 and Table 2.5 are place of residence in 1997.
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Figure 2.4: Marginal effect of blood lead on IQ outcomes
tests.22 Again, blood lead remains highly significant with an estimated marginal effect of 2.7 per-
centile point reduction in IQ for a 1 µg/dL increase in BLL (95% CI: -0.04, -0.014). The sign
of the coefficient estimate for Endowment is in line with expectations, with IQ percentile score
increasing in mother’s age and the educational attainment of the respondents parents. A standard
deviation increase in the endowment variable increases cognitive IQ by 9.2 percentage points. Fi-
nally, sensitivity tests are included in Columns 6 and 7. When controls for sex and racial status
are removed, the results are largely unchanged and remain highly statistically significant in both
cases. Results of Table 2.4 are illustrated in Figure 2.4, Panel A. Here, the estimated marginal
effects are based on the linear-linear specification shown in Table 2.4, Column 4. The linear-log
and and log-log variations have been included for comparison. Together, the marginal effects of
blood lead on IQ shown in Panel A highlight the significant dose response relationship across all
three functional forms.
22The variable Endowment is the predicted first principal component across the following dimensions: age of
the respondent’s biological mother at the time of birth, educational attainment of the respondent, and educational
attainment of both his biological mother and father.
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Converting the continuous IQ outcome to an indicator for a low-IQ ASVAB score, we re-
estimate the models used in Table 2.4 and present results in Table 2.5. Here, we define the outcome
as low-IQ=1 for respondents with ASVAB scores in the at or below the 25th percentile and zero
otherwise. Controls are the same as those found in Table 2.4, including fixed effects for state of
residence, NLSY97 sample group, and birth year.23 The coefficient estimates for blood lead are ex-
pected to be strictly positive following the results in Table 2.4 where IQ is statistically significantly
decreasing in blood lead exposure.
Again, emphasis is placed on the saturated model in Column 4 of Table 2.5. The spare model in
Column 1 suggests a 1 µg/dL increase in BLL increases the probability of falling into the low-IQ
group by an estimated 2.8 percentage points (95% CI: 0.015, 0.039), and an estimated 3.2 percent-
age points when cohort fixed effects are added in Column 2. The inclusion of state of birth fixed
effects in Column 3 raises the marginal effect of BLL on the probability of a low-IQ outcome by
an estimated 7.7 percentage points (95% CI: 0.059, 0.094). Household income to FPL quartiles
are included in Column 4, and the estimated marginal effects on a low-IQ outcome, decrease in in-
come relative to the lowest income group. BLL, sex and minority status remain highly statistically
significant, with an estimated 4.3 percentage point increase in the probability of a low-IQ outcome
per 1 µg/dL increase in BLL (95% CI: 0.025, 0.06). In Column 5, the previously described com-
posite index variable Endowment is introduced and the coefficient estimate is non-positive and
highly significant. Given the inter-generational relationship of educational attainment, the coef-
ficient estimate of -0.099 for endowment is within plausible range. The coefficient estimates for
blood lead and minority remain statistically significant but are reduced to 0.039 and 0.088 respec-
tively. Columns 6 and 7 of Table 2.5 are included as sensitivity tests based on the saturated model
used in Column 4. As with Table 2.4, the exclusion of Sex in Column 6 does not result in a signif-
icant change on the estimated effect of BLL, nor does the exclusion of Minority status in Column
7. In both cases, the underlying lead exposure – IQ outcome channel remains highly statistically
significant.




Table 2.5: Low-IQ effect of blood lead, linear probability regressions
(1) (2) (3) (4) (5) (6) (7)
Blood Lead (µg/dL) 0.028*** 0.032*** 0.077*** 0.043*** 0.039*** 0.046*** 0.065***
(0.006) (0.006) (0.009) (0.009) (0.011) (0.009) (0.009)
Sex 0.048*** 0.046*** 0.045*** 0.052*** 0.038*** 0.048***
(0.012) (0.012) (0.012) (0.012) (0.013) (0.012)
Minority 0.232*** 0.224*** 0.097*** 0.114*** 0.088*** 0.108***
(0.033) (0.034) (0.030) (0.025) (0.030) (0.025)
Poverty Ratio (Q1 Reference Group)
Poverty Ratio Q2 -0.113*** -0.053** -0.108*** -0.107***
(0.020) (0.026) (0.021) (0.020)
Poverty Ratio Q3 -0.187*** -0.072*** -0.182*** -0.177***
(0.023) (0.024) (0.023) (0.025)
Poverty Ratio Q4 -0.242*** -0.042* -0.238*** -0.237***
(0.025) (0.025) (0.025) (0.026)
Endowment -0.099***
(0.004)
Constant 0.031 -0.025 -0.415*** 0.003 -0.066 -0.001 -0.119
(0.055) (0.061) (0.091) (0.097) (0.107) (0.099) (0.109)
Observations 4,587 4,587 4,587 4,587 3,219 4,587 4,587
R2 0.145 0.146 0.185 0.213 0.275 0.210 0.208
State FE No No Yes Yes Yes Yes Yes
Cohort FE No Yes Yes Yes Yes Yes Yes
Oversample FE Yes Yes Yes Yes Yes Yes Yes
Notes: Dependent variable is low-IQ, where low-IQ=1 for ASVAB score ≤ 25th percentile; Robust state clustered errors
in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1; Blood lead is predicted mean blood lead in µg/dL; Poverty ratio
quartiles are based on household income to poverty ratio, 1997 (survey round one); Endowment is the first principle
component among mother’s age at respondent’s time of birth, and years of education for the respondent and biological
mother and father; State of residence, over-sample group, and cohort fixed effects included where noted;
Panel B in Figure 2.4, illustrates the dose response relationship estimated in Table 2.5, Col-
umn 4, with a linear-log variation included for comparison. Results of additional sensitivity and
robustness tests of the blood lead – IQ channel are included in Appendix Table C.2.
Now that we have established a link between childhood lead exposure and cognitive intelli-
gence in early adulthood, we turn attention to the possible link between child BLLs and abnormal
risk preferences in various specific domains of risk.
Beginning with descriptive analysis, consider Figure 2.5 depicting the relationship between
average childhood BLL and risk preference questions collected during rounds 14 and 15 of the
NLSY. Along the x-axis are response values from the NLSY97 risk preference sample, plotted
against respondent’s BLLs in units of µg/dL on the y-axis. Sample means for each risk preference
question are identified by the vertical reference lines.24 In each case, the sample mean response is
nearest to the minimum sample mean BLL. One can also see that average BLLs are substantially
higher at both ends of the response distribution. For both the left tail (least willing to accept risk)
and the right tail (completely willing to accept risk), mean BLLs increase sharply. Compatible with
the expectations from the field of abnormal psychology, early childhood lead exposure increases
the likelihood of risk preferences in adulthood deviating from central tendency.
Results modeling the effect of blood lead on abnormal risk preferences are presented in Ta-
ble 2.6. Recall, the dependent variable is constructed using Equation 2.1 detailed in Section 2.3.1,
constituting a measure of deviation from central tendency with respect to self reported risk prefer-
ences. Control variables match those of Table 2.4, though Table 2.6 has been truncated for clarity.
Full results for the models in which blood lead is statistically significant are included in Appendix
Table C.3.
Across a series of contexts, we find that childhood BLLs significantly increase deviation from
normal willingness to assume risk in adulthood. Specifically, a 1 unit increase in child BLL,
increases deviation from the norm by 2.1% for driving, 2.3% for personal finances, 2.9% for work,
24Modified survey sample weights have been applied to account for non-response as well as observations for which
BLLs could not be assigned. See National Longitudinal Survey of Youth 1997 cohort for the NLSY’s documenta-




Figure 2.5: Abnormal risk preferences and blood lead
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Table 2.6: Abnormal risk response (mean deviation) effect of blood lead, linear regressions
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10)
General Drive Finance Work Health People Romance Life Gamble Overall
Blood Lead (µg/dL) 0.007 0.021* 0.023*** 0.029*** 0.034* 0.014 0.017** 0.010 0.024** 0.017***
(0.010) (0.011) (0.008) (0.008) (0.019) (0.011) (0.009) (0.018) (0.012) (0.005)
Constant 0.449*** 0.613*** 0.291*** 0.333*** 0.144 0.594*** 0.737*** 0.114 0.736*** 0.791***
(0.104) (0.120) (0.107) (0.107) (0.237) (0.122) (0.108) (0.211) (0.126) (0.056)
Observations 4,224 4,224 4,224 4,224 4,224 4,224 4,224 4,224 4,224 4,224
R2 0.046 0.040 0.046 0.033 0.044 0.031 0.031 0.026 0.019 0.099
State FE Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Cohort FE Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Controls Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Notes: Dependent variables are abnormal risk preferences (mean deviation), based on NLSY97 survey responses; Robust state
clustered errors in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1; Blood lead is predicted mean blood lead in µg/dL; Indicators
controlling for for sex (Sex=1 if male), minority status (Minority=1, if non-white), and marital status (Married=1 if married when
surveyed); Poverty ratio quartiles are based on household income to FPL poverty ratios; State of residence, age cohort, and over-
sample survey group fixed effects included in all regressions;
Figure 2.6: Marginal effect of blood lead on abnormal risk response
3.4% for personal health, 1.7% for romantic relationships, 2.4% for gambling, and 1.7% overall
(representing the average across all variables).
Figure 2.6 illustrates the estimated marginal effect of blood lead across the response surface.
Across the subset of outcomes with an estimated statistical significance of at least 90%, the esti-
mated dose response is linear and near uniform across all risk preference outcomes.
2.4.2 Robustness and falsification
Robustness results are included in Table 2.7, which replace blood lead with average gasoline
lead concentrations (TEL). Borrowing the same set of regressors as those found in Table 2.4,
the results are similar to those above. Across all four models, TEL has a statistically significant
negative impact on IQ. At the 90% confidence level, a 1 g/gal increase in TEL reduces IQ by an
estimated 11 to 15 percentile points. The controls for sex, minority status, and household income
behave in a similar manner to those in Table 2.4.
As a falsification test, we model the effect of blood lead against an individual’s dominant hand
preference while writing and throwing. Borrowing the same notation in Equation 2.8, let s be the
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Table 2.7: Robustness tests of IQ outcomes and average gasoline lead (TEL) concentrations
(1) (2) (3) (4) (5) (6)
IQ Percentile IQ Percentile IQ Percentile Low-IQ Low-IQ Low-IQ
Gasoline Lead (g/gal) -0.059** -0.166** -0.120* 0.099** 0.215** 0.155**
(0.028) (0.066) (0.061) (0.044) (0.086) (0.074)
Sex -0.027*** -0.027*** -0.029*** 0.054*** 0.054*** 0.057***
(0.009) (0.008) (0.008) (0.012) (0.012) (0.011)
Minority -0.206*** -0.203*** -0.152*** 0.283*** 0.280*** 0.211***
(0.019) (0.018) (0.016) (0.029) (0.028) (0.025)
Poverty Ratio (Q1 Reference Group)
Poverty ratio Q2 0.093*** -0.151***
(0.015) (0.019)
Poverty ratio Q3 0.166*** -0.242***
(0.011) (0.023)
Poverty ratio Q4 0.228*** -0.292***
(0.013) (0.021)
Constant 0.536*** 0.601*** 0.453*** 0.213*** 0.141** 0.345***
(0.028) (0.053) (0.048) (0.040) (0.067) (0.059)
Observations 4,587 4,587 4,587 4,587 4,587 4,587
R2 0.173 0.176 0.252 0.137 0.138 0.191
State FE No No No No No No
Cohort FE No Yes Yes No Yes Yes
Oversample FE Yes Yes Yes Yes Yes Yes
Age (months) 13-24 13-24 13-24 13-24 13-24 13-24
Notes: Dependent variables are percentile score on ASVAB examination and low IQ (<25th percentile) indicator;
Robust state clustered errors in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1; Gasoline lead concentrations
(g/gal), calculated as the 12 month state average for each respondent, by state of and year of birth; Indicators are
defined as: Sex=1 if male, Minority=1 for non-white race; Poverty ratio quartiles are based on household income
to poverty ratio, 1997 (survey round one); State of residence, over-sample group, and cohort fixed effects included
where noted;
state of residence during childhood and t denote the year in which survey round 1 was conducted
(1997). Then for individual i, residing in state j we estimate effect of childhood lead exposure on
dominant hand preference using the following linear probability model:
Hijt = α + β1B̂LLijs + X ijt
′β + Γ1Rj + Γ2Zt + ǫijt (2.9)
where, all terms carry from Equation 2.8 and the dependent variable H represents one of two
dichotomous outcomes to be modeled: Writing or Throwing. We define Writing=1 if individ-
ual i writes left-handed and zero otherwise, and Throwing=1 if i throws right-handed and zero
otherwise.
There is no evidence in scientific literature linking early in life lead exposure to the develop-
ment of a dominant hand in these activities. Therefore, expectations are that the predicted blood
lead effect on dominant hand preferences are insignificant in all cases. The sample descriptive
statistics in Table 2.3 illustrate this random process as the sample means for both Writing and
Throwing outcomes mirroring the means across BLL quintiles.
Results of this strategy are presented in Table 2.8. The dependent variables are indicators for
whether a respondent is left handed while writing (Writing=1) or right handed while throwing
(Throwing=1). Fitting linear probability models, the estimates in Table 2.8 show that blood lead
is not a statically significant predictor of dominant hand preference. These results hold across the
five specifications which are based on those used in the primary analysis, and vary with respect to
the choice of covariates and fixed effects included.
Figure 2.7 graphs the estimates of the fully saturated models shown in Table 2.8, Columns
2 and 5. A linear-log specification has been included for comparison. For both outcomes, left-
handed throwing (Panel A) and right-handed writing (Panel B), the estimated marginal effect is
statistically insignificant across the response surface.
60
Table 2.8: Dominant hand effect of blood lead falsification test, linear probability
regressions
(1) (2) (3) (4) (5)
Writing Writing Throwing Throwing Throwing
Blood Lead (µg/dL) -0.001 -0.002 -0.000 -0.002 -0.003
(0.004) (0.004) (0.003) (0.003) (0.003)
Sex -0.025** -0.025** 0.020** 0.020** 0.021**
(0.012) (0.012) (0.008) (0.008) (0.008)
Minority -0.017 -0.024* 0.018 0.021 0.015
(0.011) (0.012) (0.013) (0.014) (0.013)
Age -0.004 -0.004 0.004 0.006**
(0.003) (0.003) (0.003) (0.003)
Constant 1.008*** 1.023*** 0.074** -0.030 -0.031
(0.083) (0.084) (0.031) (0.075) (0.073)
Observations 4,362 4,362 4,555 4,555 4,361
R2 0.016 0.017 0.011 0.012 0.016
State FE Yes Yes Yes Yes Yes
Oversample FE No Yes Yes Yes Yes
Poverty Ratio FE Yes Yes No No Yes
Notes: Dependent variables are indicators for left-handed while writing (Writ-
ing=1) and right-handed while throwing (Throwing=1); Robust state clustered
errors in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1; Blood lead is
predicted mean blood lead in µg/dL; Indicators for sex (Sex=1 if male) and
minority status (Minority=1 if non-white); Age is respondent’s age in years
when surveyed; Fixed effects for income to poverty ratio quartiles, state of
residence, and over-sample group included where noted;
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Figure 2.7: Falsification test of blood lead effect on dominant hand, predicted margins
2.5 Discussion and conclusion
Leveraging the spatial and temporal variation in lead exposure resulting from the differential
phase-out of leaded gasoline, we find evidence in support of the lasting effects of early in life lead
exposure on cognitive impairment and abnormal risk preferences in adulthood. Through an ensem-
ble of evidence, we find that an increase in average childhood blood lead levels: 1) decreases IQ
as measured by scores on the ASVAB examination; 2) increases the likelihood of a low-IQ (lowest
quartile) ASVAB score; and 3) increases the extent to which responses to risk and uncertainty de-
viate from the norm. These findings are consistent across a number of alternative specifications of
the treatment variable, blood lead levels (µg/dL), including log transformation and converted to a
set of binary variables by quintiles. Sensitivity tests in which the treatment variable is substituted
with average gasoline lead produces similar results. Furthermore, we lean against the identifica-
tion strategy underlying the analysis with a divergent validity test in which the blood lead effect on
individual’s dominant hand preference is estimated.
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The legacy of lead in the United States is complex and intertwined with public health. As
concerns over the toxicity of lead have grown over time, policy makers have responded with a
series of national policies aimed at minimizing exposure to lead across society. Our analysis of the
phase out of lead in gasoline under the Clean Air Act adds to the body of research relating early
in life lead exposure to later in life outcomes. Over a fifteen year period between 1975 to 1990,
enforcement of the policy would significantly reduce the risk of lead exposure by stemming the
flow of lead into the environment from automobile emissions, the primary source of environmental
lead at the time. Despite the immense returns to public health from the policy, our findings suggest
the legacy of this period in US history will persist into the future, both in the lives of individuals




Heavy metal and light babies: Maternal lead
exposure and birth outcomes: Evidence from natural
experiments in the phase-out of leaded gasoline
3.1 Introduction
The health and human capital costs of lead exposure in early childhood are lasting and sub-
stantial. Studies link elevated blood lead in childhood to physical health problems in adulthood,
including hypertensive disorders and the malfunction of renal and cardiovascular systems. The in-
tellectual and behavioral effects of lead exposure include poor academic achievement and impaired
cognition, increased risk of attention-deficit and hyperactivity disorders, aggression and violence
and ensnarement in the criminal justice system. Brain imaging studies find that adults exposed to
lead as children have reduced gray matter in brain regions that govern judgment and mood regu-
lation (Cecil et al., 2008; Cecil, 2011). Mood regulation is a socioemotional trait that economists
have linked convincingly to long-term life outcomes (Cunha et al., 2010; Almond and Currie,
2011; Doyle et al., 2013). On the long reach of lead exposure, Reyes (2015) has linked elevated
blood lead levels in childhood to “an unfolding series of adverse behavioral outcomes: behavior
problems as a child, pregnancy and aggression as a teen, and criminal behavior as a young adult.”
It might be tempting to assume that lead exposure is a rear-view problem, at least in the United
States. Blood lead levels in children in the United States have fallen since the 1990s, coincident
with a series of actions that banned lead from paint, plumbing, food cans and automotive gasoline.
However, lead remains a constituent in aviation gasoline used by an estimated 160,000 piston-
engine aircraft. These aircraft consume over 200 million gallons of avgas annually (Kessler, 2013),
implying a flow into the environment of about a million pounds of lead. For the estimated 16
million people–and 3 million children–who live within a kilometer of airport facilities that service
piston-engine aircraft, the atmospheric disposition of lead-formulated aviation gasoline remains a
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potentially serious source of exposure risk. In fact, studies have shown that children proximate to
airports with piston-engine aircraft traffic have elevated blood lead levels (Miranda et al., 2011;
Zahran et al., 2017b).
Unlike other criteria pollutants, lead is a metal that persists in the lived environment, painted on
interior and exterior walls of homes built prior to 1960 and accumulated in urban soils. Children
in the United States are exposed to these legacy sources of lead as dust associated with deteri-
orating or haphazardly removed lead-based paint in renovation or demolition of homes (Farfel
et al., 2003, 2005a; Rabito et al., 2007), and through the ingestion of contaminated soils (involving
hand-to-mouth behaviors) or inhalation of lead-concentrated soils re-suspended in summer months
(Filippelli et al., 2005; Laidlaw et al., 2005, 2012; Zahran et al., 2013). Studies find that children
residing in neighborhoods with high soil lead concentration are at higher risk of elevated blood
lead levels (Mielke et al., 2007; Zahran et al., 2010, 2011, 2013).
Child exposure to lead therefore remains a risk in the United States through the flow source of
aviation gasoline, and through the legacy sources of paint, soil/dust and water. As noted, these
sources typically enter a child’s body through inhalation and ingestion. An underappreciated
medium of child exposure to flow and legacy sources of lead is through maternal blood trans-
mission in pregnancy. Transmission of lead to the fetus occurs via diffusion across the placental
barrier over the course of a pregnancy. Child lead exposure and consequent development therefore
has a fetal origin (Almond and Currie, 2011).
To evaluate the maternal blood transmission exposure pathway, we leverage the phase out of
leaded gasoline following the passage of the Clean Air Act (CAA). The result of this policy was
significant reduction in the concentrations of lead in leaded gasoline grades between 1975 and
1985, and eventual removal in 1990. Though the policy was implemented at the national level,
enforcement was at the producer level, creating significant variation in lead emissions from au-
tomobile exhaust across states and over time. We leverage this variation in lead emissions as a
quasi-random vector of lead exposure, as lead dust from automobile emissions was a significant
source of lead exposure. Using sales of leaded gasoline along with gasoline lead concentrations
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data during the initial period of the phase out as a lead exposure channel, we estimate the causal
effect of maternal lead exposure on birth outcomes between 1976 to 1980.
Across an ensemble of tests, we find that an increase in maternal blood lead: 1) decreases
infant birthweight; 2) increases the risk of low and very low birthweight; 3) shortens gestation
length; 4) increases the risk of prematurity; and 5) increases the risk of a low APGAR score.
These results are robust to various operations of our treatment variable, the relaxation of inclusion
criteria, accounting for possible fertility selection effects, and various convergent validity tests.
Moreover, we satisfied a divergent validity test by falsifying our causal channel of maternal blood
lead with analyses of the lead-independent outcome of infant sex. Taken together, these results
suggest considerable social and economic benefits from the phase-out of leaded gasoline in the
United States through improved infant health. Calculating the economic benefits of the phase-
out of leaded gasoline through the reduction of healthcare-related costs involved in treating low
birthweight infants, alone, are in the tens of billions annually.
The rest of our manuscript is organized as follows. In Section 3.2 we discuss relevant scientific
literature on the maternal transmission pathway and studies linking to deleterious birth outcomes
to lead exposure. In Section 3.3, we detail elements of research design, including data collection
efforts, variable operations and econometric strategies to identify the relationship between maternal
lead exposure and birth outcomes. In Section 3.4 we present a series of results on the fetal effects of
maternal lead exposure, including a series of robustness and falsification analyses. In Section 3.5,
we conclude with a recapitulation of key findings, a narrow benefit analysis from the phase-out of
leaded gasoline through the maternal blood lead exposure pathway, and discussion of the present
challenges of limiting lead exposure in the United States and abroad.
3.2 Literature review
Lead typically enters the body through inhalation of lead dust or consumption of contaminated
foods and liquids. Though the majority of lead is either exhaled or passed through the body in solid
waste or urine, that which remains enters the circulatory system (Papanikolaou et al., 2005; Clay
et al., 2018). Once lead enters the bloodstream it is transmitted throughout the body, accumulating
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in soft tissue, bone, and blood (Needleman, 2004; Papanikolaou et al., 2005). The half life of lead
in blood is approximately 35 days and four to six weeks for lead in soft tissue (Papanikolaou et al.,
2005), though lead deposits in the brain has a half life of approximately two years (Lidsky and
Schneider, 2003). Lead deposited in bone has an estimated half life of 20 to 30 years (Papanikolaou
et al., 2005), and can re-enter the bloodstream during periods of high physiological stress such as
pregnancy, lactation, and postmenopausal osteoporosis (Bellinger et al., 1987; Rothenberg et al.,
1994; Needleman, 2004; Papanikolaou et al., 2005; Bellinger, 2011). Using isotopic measurements
of blood lead during pregnancy, cross county analysis have found bone lead is re-mobilized at a
higher rate during pregnancy, with skeletal lead attributable to approximately 30% of maternal
blood lead levels during this period (Gulson et al., 1997a; Hertz-Picciotto et al., 2000; Harville
et al., 2005).
Transmission of maternal blood lead to the fetus occurs via diffusion across the placental barrier
over the course of the pregnancy and beginning at week twelve (Gershanik et al., 1974; Rothenberg
et al., 1994; Harville et al., 2005). It is generally accepted that lead passes freely through the
placental wall. Studies find that measured blood lead levels in a fetus are on average 70% of the
mother’s blood lead level (Gershanik et al., 1974; Cavalleri et al., 1978; Papanikolaou et al., 2005).
Due to the consistent and significant correlation of this relationship, measuring umbilical cord lead
levels relative to maternal blood lead is commonly used as a less invasive indicator of in-utero
lead exposure in clinical studies (Rothenberg et al., 1994; Gulson et al., 1997a,b; Harville et al.,
2005). Identification of the underlying biological and chemical determinants of this transmission
channel has proven challenging, as many of the factors influencing maternal lead exposure, both
prior to and during pregnancy, are exogenous (Bellinger et al., 1987; Bellinger, 2017; Schell et al.,
2003). For example, studies which have focused on maternal behavior and dietary intake during
pregnancy have returned mixed results (Gulson et al., 1999, 2000; Harville et al., 2005; Rothenberg
et al., 1994). While the biochemistry remains open to debate, there is a consensus in the literature
showing a highly positive correlation between maternal and infant blood lead.
Interdisciplinary studies have examined how lead exposure affects infant development during
pregnancy as well as birth outcomes. Using the contamination of lead in drinking water of Flint
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MI and surrounding areas, Grossman and Slutsky (2017) find a significant reduction in fertility
rates and newborn health relative to similar Michigan cities following the switch to the Flint River
and elevated lead levels in the water supply. Clay et al. (2018) find similar results using lead
content from soil samples to show reduced fertility rates at the national scale. Other authors have
identified the impact of vehicle emissions and environmental toxins on birth outcomes. Using the
replacement of toll plazas with EZ-Pass systems, Currie and Walker (2011) found that improved
air quality in neighboring areas reduced the incidence of low birthweight children by 8-11% and
premature births by 7-9%.
Evidence supporting the consequences of lead exposure and environmental pollutants on birth
outcomes continues to mount, though accounting for the costs is a challenge. Economists have
shown that low birthweight babies fare worse in school performance and educational attainment,
labor market outcomes, and worse health in adulthood (Currie and Hyson, 1999; Currie, 2009;
Behrman and Rosenzweig, 2004; Almond et al., 2005; Almond and Currie, 2011; Black et al.,
2007). In Almond and Currie (2011), the authors argue that the dynamic relationship between
environmental conditions during pregnancy, exposing the unborn child to pollutants, resulting in
deleterious epigenetic dynamics realized years later. In the next section we describe our research
design to identify the relationship between maternal lead exposure and birth outcomes.
3.3 Methods
3.3.1 Data and measurement
Leaded gasoline data
Following a methodology advanced by Reyes (2007), we construct time series of the average
concentration of Pb per gallon of gasoline sold (TEL) and total Pb emissions (PbE) at the state
scale and over the period of interest. The data sources used to construct and series are detailed
below.
Annual Sales of Leaded Gasoline
Annual gasoline sales for the years 1977-1980 are drawn from the “Yearly Report of Gasoline
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Sales, by States,” published by Ethyl Corporation. Ethyl was the primary supplier of the TEL
additive used in gasoline from introduction in the 1920’s until removal in 1990 and published
annual marketing reports for the petroleum industry. We calculate total gasoline sales (Qjt) for
state j in year t by summing total sales for each grade sold.
During the phase-out period, gasoline was sold to consumers in four grades: premium (p),
regular (r), premium-unleaded (pu), and regular-unleaded (ru).25 From Ethyl reports we exploit
information on total sales of each grade as well as shares of each grade in total sales. Defining the
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jt = 1 for each state j and year t ∈ {1977, ..., 1980}.
TEL Concentrations
Data on TEL concentrations for both regular and premium gasoline grades are from the “Petroleum
Products Survey: Motor Gasolines, Summer” published annually by the National Institute for
Petroleum Research (NIPER) under the Department of Energy. Samples of gasoline were taken
each year from 17 districts across the United States. TEL concentrations were reported in grams
per gallon (g/gal.) for both regular (“leaded non-premium”) and premium (“leaded premium”).
Using sg from Equation 3.2 as weights, and letting telg denote the TEL concentration for grade g,
TELjt is calculated as the sum of concentration tel
g
jt times the share s
g
jt of total sales across all
gasoline grades g ∈ G, in a given state:
25Premium (p), regular (r), and regular-unleaded (ru) gasoline sales are observed over the entire observation period,










Since TEL concentrations for both unleaded grades (telpu, telru) are effectively zero, these










This calculation is rendered for all states and each year from 1977 to 1980 and constitutes the
primary channel of maternal lead exposure throughout the study.
Pb Emissions
Finally, using both annual sales of leaded gasoline and TEL concentration data, we construct an
annual time series of Pb emissions (PbE) at the state level over the period of interest. Total PbE
in metric tons is calculated as the product of leaded gasoline sales (q) times average gasoline lead
concentrations (tel) from NIPER reports. This is done for each state j and year t. Recall, total sales
of leaded gasoline (millions of gallons) for leaded gasoline grade g is q
g
jt, and lead concentration
per gallon of gasoline sold is tel
g










Equation 3.5 produces PbE in metric tons, as total sales are in millions of gallons and tel
concentrations are in g/gal. While TELjt is our primary lead exposure operation, we use PbEjt
to test the robustness of statistical claims linking maternal Pb exposure to deleterious infant health
outcomes.
Natality files
Birth data (1977-1980) were obtained by National Bureau of Economic Research’s inventory of
natality files from the National Vital Statistics System of the National Center for Health Statistics.
Birth data include unique information on the date of birth, spatial information on county of mater-
nal residence and place of birth occurrence, as well as a host of birth outcomes and demographic
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information on infants and birth mothers. We focus analysis on singleton births of plausible ges-
tation age (greater than 20 weeks) whose delivery occurred in state with complete reporting of all
births in the observation period of interest.
Our response variables include infant birthweight (measured in grams), low birthweight sta-
tus = 1 if a child’s birthweight is < 2, 500g, very low birthweight status = 1 if a child’s birth-
weight is < 1, 500g, gestation length (measured in weeks), premature status = 1 if a child is born
at < 37 weeks of gestation, and low APGAR = 1 if a child’s APGAR score at 1 minute of life is
< 7. Control variables include various maternal and infant characteristics associated with delete-
rious birth outcomes. Variables include maternal education, age, race, interval since last birth
and child sex.26 All models also include fixed effects for county of maternal residence, year and
month of birth.
3.3.2 Empirical model
Using natality data, we estimate the causal effects of maternal lead exposure on birth outcomes
(B) for child i, born at time t in county j with the following model:
Bijt = α + β1BLLit + Xijt
′β + ǫijt (3.6)
where, X is vector of control variables, measuring maternal and infant characteristics (including
maternal education, age, race, interval since last birth and child sex) that affect birth outcomes
of child i. The variable of theoretical interest is BLLit, reflecting maternal blood lead concentra-
tion (µg/dL) of mother i in time t.
Because maternal blood lead information is not available in natality data, we estimate the blood
lead concentration of mothers using a split sample, two-stage least squares approach that leverages
National Health and Nutrition Exam Survey (NHANESII) data from the National Center for Health
26Maternal age is a categorical variable (1 = Under 20 years of age; 2 = 20-24 years; 3 = 25-29 years; 4 = 30-34
years; 5 = 35-39 years; and 6 = 40-49 years); maternal race is measured dichotomously (0 = white; 1 = non-white);
maternal education is a categorical variable (1 = 0-8 years; 2 = 9-11 years; 3 = 12 years; 4 = 13-15 years; 5 = 16
year and over; 6 = Not stated); maternal interval since last live birth is measured categorically (2 = 1-11 months; 3 =
12-23 months; 4 = 24-35 months; 5 = 36-47 months; 6 = 48-71 months; 7 = over 72 months; 8 = Not stated); and
infant sex is a binary variable (female = 0; male = 1).
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Statistics. Specifically, we make use of NHANESII, a nationally representative sample of the US
population that unfolded between 1976 and 1980, a period that is coincident with observed natality
birth data. Of the 27,801 persons sampled in NHANESII, a sizable fraction underwent various tests
of anthropometry, hematology, serology, and biochemistry. A total of 10,049 participants had their
blood evaluated for Pb, measured in µg/dL units. Residential location of NHANESII participants
(at the state scale) allows us to statistically link blood lead outcomes to exposure risk in females
of reproductive age. Weighted least squares coefficient estimates from the analysis of NHANESII
data inform blood lead estimates in our natality population (Solon et al., 2013).
Importantly, over the four-year period of interest (1977 to 1980), much of the historic phase
out of leaded gasoline occurred. As shown in Figure 3.1, Panel A, all states experienced reductions
in gasoline-related Pb emissions of at least 40% over this period. The decrease in Pb emissions
ranged from 65% in Michigan to 40% in Montana. Reductions in Pb emissions were driven largely
by reductions in the TEL concentration of gasoline sold. As shown in Panel B, the reduction in
total emissions is driven largely by the reduction in the concentration of TEL per unit of gasoline
sold not the quantity of gasoline sold. In terms of the change in concentration, reductions ranged
from 62.0% in Washington to 37.9% in Montana.
Since the rate of lead entering the environment during this period declined precipitously and
exogenously across states, our estimates of the exposure channel in the first stage are defensibly
representative of the population over the same period. Therefore, the first stage regression equation
of blood lead level (BLL) on TEL, using the NHANESII survey is summarized as follows:
BLLit = α + γTELjt + Yit
′θ + ǫit (3.7)
where, Y is a vector of controls for the respondent’s age, sex, race, and educational attainment.
The variable TEL is the measured concentration of lead per gallon gasoline in state i in year t
defined by Equation 3.4. Using the coefficient estimates obtained from Equation 3.7 and the same
set of regressors, we then predict blood lead levels for each mother in natality files. The predicted
blood lead values are described in Equation 3.8.
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Figure 3.1: Pb emissions (tonnages per 1,000) and average TEL concentration (g/gal) exposure risk by state in time
B̂LLit = α̂ + γ̂TELjt + Yit
′θ̂ (3.8)
Substituting estimated blood lead from Equation 3.8 into equation produces the final model to
be used in analyses:
Bijt = α + β1B̂LLijt + X
′
ijtβ + Γ1Zt + Γ2M t + Γ3Cj + ǫijt (3.9)
where, again, X is vector of control variables, measuring maternal and infant characteristics (in-
cluding include maternal education, age, race, interval since last birth and child sex) that
affect birth outcomes specific to child i. Zt is the year of birth, measured as a series of dummy
variables with 1977 constituting our reference year, Mt is the month of birth, again measured as a
series of dummy variables with January as our reference month, and Cj is the county of maternal
residence j at the time of birth. The coefficient of analytic interest is β1, reflecting the effect of
maternal blood lead level BLLit, on various birth outcomes. The expectation is that β1 is negative
for outcomes measured continuously like birthweight (grams) and gestation length (weeks), and
positive for deleterious binary outcomes like low birthweight, very low birthweight, prematurity,
and low APGAR score.
3.4 Results
3.4.1 Evidence of lead effects
Table 3.1 presents descriptive statistics on birth outcomes by quantiles of estimated maternal
blood lead. Birth events are limited to singletons with plausible gestation length (> 20 weeks),
occurring in states with full reporting over the observation period of 1977 to 1980. In Column 1 we
observe unconditional mean birthweight of infants born to mothers grouped by blood lead level.
Mean birthweight decreases incrementally in going from Quantile 1 (Q1) to Quantile 5 (Q5). As
compared to infants born to Q5 mothers, Q1 infants weight 151 grams or 4.64% more at birth. As
shown in Column 2, the same pattern of increasing risk by maternal blood lead obtains for low
birthweight status. About 1 in 12 infants born to Q5 mothers arrive at 2,500 grams or less, whereas
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Table 3.1: Descriptive statistics on birth outcomes by quantiles of estimated maternal blood (µg/dl)
Maternal Blood Lead (µg/dL) Birthweight Low Birthweight V. Low Birthweight Gestation Length Premature Low APGAR Low APGAR
(Grams) (<2,500g) (<1,500g) (Weeks) (<37 Weeks) (<7, 1 min) (<7, 5 min)
Maternal Blood Lead Q1 3407.826 0.0473882 0.0066778 39.73966 0.0709061 0.0840116 0.0156776
(555.77) (0.212) (0.082) (2.572) (0.257) (0.277) (0.124)
Maternal Blood Lead Q2 3399.087 0.0492124 0.0067449 39.71019 0.0735085 0.0863954 0.016342
(557.86) (0.216) (0.082) (2.591) (0.261) (0.281) (0.127)
Maternal Blood Lead Q3 3387.731 0.051437 0.0073819 39.67169 0.0752023 0.0856951 0.0172108
(562.97) (0.221) (0.086) (2.610) (0.264) (0.280) (0.130)
Maternal Blood Lead Q4 3359.678 0.0569863 0.0084298 39.56352 0.0825275 0.0838764 0.0179081
(568.39) (0.232) (0.091) (2.669) (0.275) (0.277) (0.133)
Maternal Blood Lead Q5 3256.604 0.0823191 0.0132513 39.20303 0.116137 0.1003102 0.0267118
(595.47) (0.275) (0.114) (2.970) (0.320) (0.300) (0.161)
Total 3,366.086 0.0566103 0.0083296 39.59164 0.0825822 0.0867286 0.0177008
(569.80) (0.231) (0.091) (2.684) (0.275) (0.281) (0.132)
6,332,747 6,332,747 6,332,747 6,332,747 6,332,747 3,858,278 3,870,901
Notes: Birth events are limited to singletons with plausible gestation length (>20 weeks), occurring in states with full reporting over the observation
period of 1977 to 1980; Mean and standard deviation of blood lead (µg/dL) of mothers in: Q1 (9.63, 0.50), Q2 (10.72, 0.24), Q3 (11.46, 0.20), Q4
(12.21, 0.24), and Q5 (13.70, 0.92).
about 1 in 20 children born to Q1 mothers are at risk of low birth weight. With respect to gestation
length in Column 4, on average, Q1 infants age 3.8 days longer in womb than Q5 infants (39.74
weeks vs 39.20 weeks). With the exception of a low APGAR score (< 7) at 1 minute of life, all
birth outcomes worsen dose-responsively in the estimated blood lead of mothers.
Figure 3.2, Panel A presents a kernel density plot of infant birthweight (grams) and Panel
B displays a histogram of infant gestation length (weeks) by Q5 versus Q1 blood lead mothers.
The negative effect of maternal blood lead appears to operate more or less uniformly across the
unconditional distributions of infant birthweight and gestation length, shifting each distribution
toward the origin.
Table 3.2 reports the birthweight effects of maternal blood lead, involving various combinations
of time and county fixed effects, a suite of control variables, and transformations of both response
and treatment variables. Interpretive emphasis is on fully saturated models in Columns 3, 6 and
9. In Column 3 we find that, other things held equal, a 1 microgram per deciliter increase in
maternal blood lead reduces infant birthweight by 19.83 grams (95% CI: -24.30 to -15.36). In
Column 6 we find that the birthweight elasticity of maternal blood lead is 0.108, with a 1 percent
increase in maternal blood lead decreasing infant birthweight by a tenth of one percent (95% CI:
-0.124 to -0.093). In Column 9, maternal blood lead is divided into five quantiles. As compared
to infants born to reference group mothers in Q1, newborns to Q5 mothers are 46.78 grams (95%
CI: -60.89 to -32.67) lighter. The mean blood lead concentration differential of mothers in Q5
versus Q1 is 4.1 micrograms per deciliter. Estimated coefficients of the negative birthweight effect
of maternal blood lead increase incrementally in quantiles, going from -11.49 (Q2) to -23.29 (Q3)
to -34.24 (Q4) and to -46.78 (Q5), indicative of a linear dose-response relationship between infant
birthweight and maternal blood lead level. Appendix Table C.4 shows birthweight effects involving
the substitution of our treatment variable of maternal blood lead for TEL concentration (g/gal),
Appendix Table C.5 substitutes our exposure variable as PbE, and Appendix Table C.6 shows
birthweight effects where analyses are extended to livebirth events in all states, regardless of the
completeness of reporting. Results behave similarly across treatment variable substitutions and
sample extensions.
76
Notes: Birth events are limited to singletons with plausible gestation length (> 20 weeks),
occurring in states with full reporting over the observation period of 1977 to 1980.
Figure 3.2: Kernel density plot of birthweight (grams) and histogram of gestation
length (weeks) by q5 versus q1 maternal blood lead
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Table 3.2: Birthweight (grams) effect of maternal blood lead
(1) (2) (3) (4) (5) (6) (7) (8) (9)
BW BW BW BW ln BW ln BW BW BW BW
Maternal Blood Lead (µg/dL) -37.248*** -80.266*** -19.833***
(2.794) (4.588) (2.280)
ln Maternal Blood Lead (µg/dL) -278.953*** -0.334*** -0.108***
(24.306) (0.016) (0.008)
Reference (Maternal Blood Lead Q1)
Maternal Blood Lead Q2 -8.739*** -68.514*** -11.487***
(1.942) (3.314) (2.614)
Maternal Blood Lead Q3 -20.095*** -117.161*** -23.288***
(2.922) (5.285) (4.281)
Maternal Blood Lead Q4 -48.148*** -166.598*** -34.139***
(5.908) (7.027) (6.437)
Maternal Blood Lead Q5 -151.222*** -273.149*** -46.781***
(9.712) (13.262) (7.194)
Constant 3,791.346*** 4,402.041*** 3,392.100*** 3,850.772*** 8.959*** 8.297*** 3,407.826*** 3,572.108*** 3,180.017***
(28.179) (60.323) (34.407) (63.589) (0.042) (0.021) (4.043) (10.243) (16.492)
Observations 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047
R2 0.009 0.030 0.069 0.069 0.027 0.058 0.009 0.026 0.069
County FE No Yes Yes Yes Yes Yes No Yes Yes
Year FE No Yes Yes Yes Yes Yes No Yes Yes
Month FE No Yes Yes Yes Yes Yes No Yes Yes
Controls No No Yes Yes No Yes No No Yes
Notes: Robust county clustered errors in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1; All models limit to singletons with plausible gestational length (> 20 weeks);
Control variables include: maternal age (1 = Under 20 years of age; 2 = 20-24 years; 3 = 25-29 years; 4 = 30-34 years; 5 = 35-39 years; and 6 = 40-49 years); maternal
race (0 = white; 1 = non-white); maternal education (1 = 0-8 years; 2 = 9-11 years; 3 = 12 years; 4 = 13-15 years; 5 = 16 year and over; 6 = Not stated); interval since
last live birth (2 =1-11 months; 3 =12-23 months; 4 =24-35 months; 5 =36-47 months; 6 =48-71 months; 7 =over 72 months; 8 =Not stated); and infant sex (female = 0,
male = 1).
Table 3.3 reports coefficients of the gestation length effects of maternal blood lead concentra-
tion. As with Table 3.2, interpretive emphasis is on fully saturated models in Columns 3, 6 and 9.
In Column 3, and other things held equal, we observe that a 1 µg/dL increase in maternal blood
lead decreases gestation length by 0.087 weeks (95% CI: -0.101 to -0.072) or six-tenths of a day.
Column 6 shows that the elasticity of gestation length vis-á-vis maternal blood lead is about one-
third the size of the birthweight elasticity (in Table 3.2), with a one percent increase in maternal
blood lead inducing a shortening of gestation length of -0.035 percent (95% CI: -0.040 to -0.029).
In Column 9, we find that the gestation length effect of maternal blood lead decreases progres-
sively from one maternal blood lead quantile to the next, going from -0.058 (Q2) to -0.106 (Q3) to
-0.146 (Q4) to -0.208 (Q5). On average, the gestational age of infants born to Q5 mothers is 1.5
days shorter than children born to Q1 mothers.
Taken together, Tables 3.2 and 3.3 allow one to roughly adjudicate between lead exposure
mechanisms of birthweight reduction as arising from either intrauterine growth retardation or ges-
tation length shortening. First, birthweight increases by about 90 grams per week of gestation.
Second, as shown in Column 3, Table 3.3, gestation length decreases by six-tenths of day for a
1 µg/dL increase in maternal blood lead, implying -7.7 grams of expected birthweight from ges-
tational shortening (given expected gains in birthweight per week of gestation). Given that the
estimated birthweight effect of a 1 µg/dL increase in maternal blood lead of -19.8 grams, about
39% of estimated birthweight loss is from gestation shortening, and 61% of loss is from growth
retardation.
Figure 3.3 summarizes results in Tables 3.2 and 3.3 graphically, depicting predicted birthweight
(grams) and gestation length (weeks) across a range of maternal blood lead concentrations (8 to 16
µg/dL) and three different operations of response and treatment variables. Other covariates fixed at
their means, the linear-linear (blue triangles), linear-log (orange squares), and log-log (gray circles)
models of birthweight indicate that predicted birthweight decreases from 3,434 to 3,275 grams,
3,463 to 3,279 grams, and 3,434 to 3,186 grams, respectively, in going from 1st (8 µg/dL) to 99th
percentile (16 µg/dL) in maternal blood lead concentration. While the log-log model results imply
a steeper dose-response, the 95% confidence intervals of the three specifications depicted overlap
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Table 3.3: Gestation length (weeks) effect of maternal blood lead
(1) (2) (3) (4) (5) (6) (7) (8) (9)
GL GL GL GL ln GL ln GL GL GL GL
Maternal Blood Lead (µg/dL) -0.132*** -0.314*** -0.087***
(0.010) (0.013) (0.007)
ln Maternal Blood Lead (µg/dL) -1.234*** -0.106*** -0.035***
(0.101) (0.003) (0.003)
Reference (Maternal Blood Lead Q1)
Maternal Blood Lead Q2 -0.029*** -0.310*** -0.058***
(0.006) (0.009) (0.010)
Maternal Blood Lead Q3 -0.068*** -0.516*** -0.106***
(0.010) (0.014) (0.014)
Maternal Blood Lead Q4 -0.176*** -0.716*** -0.146***
(0.018) (0.019) (0.021)
Maternal Blood Lead Q5 -0.537*** -1.113*** -0.208***
(0.034) (0.028) (0.026)
Constant 41.095*** 43.732*** 40.614*** 42.658*** 3.949*** 3.760*** 39.740*** 40.536*** 39.689***
(0.096) (0.172) (0.197) (0.301) (0.009) (0.008) (0.014) (0.024) (0.181)
Observations 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047
R2 0.005 0.019 0.027 0.027 0.019 0.028 0.005 0.016 0.027
County FE No Yes Yes Yes Yes Yes No Yes Yes
Year FE No Yes Yes Yes Yes Yes No Yes Yes
Month FE No Yes Yes Yes Yes Yes No Yes Yes
Controls No No Yes Yes No Yes No No Yes
Notes: Robust county clustered errors in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1; All models limit to singletons with plausible gestational
length (> 20 weeks); Control variables include: maternal age (1 = Under 20 years of age; 2 = 20-24 years; 3 = 25-29 years; 4 = 30-34 years; 5 =
35-39 years; and 6 = 40-49 years); maternal race (0 = white; 1 = non-white); maternal education (1 = 0-8 years; 2 = 9-11 years; 3 = 12 years; 4 =
13-15 years; 5 = 16 year and over; 6 = Not stated); interval since last live birth (2 =1-11 months; 3 =12-23 months; 4 =24-35 months; 5 =36-47
months; 6 =48-71 months; 7 =over 72 months; 8 =Not stated); and infant sex (female = 0, male = 1).
Notes: Models results depicted are fully saturated with control variables, year, month, and
county fixed effects; All covariates are fixed at sample means; The linear-linear models are
from Column 3, linear-log models are from Column 4, and log-log models are from Column 6
in Tables 3.2 (for Birthweight) and 3.3 (Gestation Length);
Figure 3.3: Predicted birthweight (grams) and gestation length (weeks) by maternal
blood lead
each other. As estimated mean (and median) blood levels of mothers decreased from about 12.5
to 10 µg/dL over the four-year observation period, depicted models imply that infant birthweights
were pushed upward by 40 to 80 grams by the phase-out of leaded gasoline.
Health economists have produced a considerable body of research estimating the birth weight
effects of social policies, including the Food Stamp Program (Almond and Currie, 2011) and the
Women, Infants, and Children (WIC) (Hoynes et al., 2011). Almond and Currie (2011), for in-
stance, find that the Food Stamp Program increased infant birth weight by 15-20 grams for whites
and 13-42 grams for African Americans. Hoynes et al. (2011), report average birthweight in-
creased approximately 29 grams, a 10 percent increase, among WIC participants. Our findings are
comparable with the effects of the Food Stamp Program and WIC on birthweight when one con-
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siders the CAA reduced lead emissions nationwide, benefiting all mothers rather than the subset of
mothers with the most to gain.
Table 3.4 reports coefficients from linear probability models estimating the effect of maternal
blood lead on risk of low birthweight (< 2, 500 grams). We focus interpretation on fully saturated
models in Columns 3 and 7. Beginning with Column 3, we find that a 1 µg/dL increase in maternal
blood lead increases the probability of a mother giving birth to a low birthweight infant increases
by nine-tenths of one percentage point (95% CI: 0.008, 0.011), or about 18%.27 Results from a
logistic regression model (not shown) supports this result, indicating that a unit increase in maternal
blood lead increases the risk of a low birthweight outcome by a multiplicative factor of 1.065 (95%
CI: 1.039, 1.092). In Column 7, maternal blood lead is divided into quantiles. The probability of
a low birthweight outcome increases progressively in maternal blood lead category. Other things
held equal, the probability of a low birthweight event for an infant born to a Q5 mother is 1.6
percentage points (or 32%) higher than infants born to Q1 mothers (0.050 versus 0.066).
In Table 3.5 we summarize linear probability models of very low birthweight risk (< 1, 500
grams). As with other birth outcomes, we find that the risk of a very low birthweight increases
substantially in maternal blood lead. Again, we focus interpretation on models reported in Columns
3 and 7 containing the full set of controls. In Column 3, we find that a 1 µg/dL increase in
maternal blood lead increases the probability of a mother giving birth to a very low birthweight
infant increases by two-tenths of one percentage point (95% CI: 0.002, 0.003). In Column 7,
maternal blood lead is divided into quantiles. The probability of a very low birthweight outcome
increases incrementally in maternal blood lead category. Other things held equal, the probability of
a very low birthweight event for an infant born to a Q5 mother is about 45.2% higher than infants
born to Q1 infants (0.010 vs 0.007).
Table 3.6 reports coefficients of the prematurity effects of maternal blood lead concentration.
Again, interpretive emphasis is on fully saturated models in Columns 3 and 7. In Column 3, and
other things held equal, we observe that a 1 µg/dL increase in maternal blood lead increases the
27The low birthweight effect size of maternal lead exposure is approximately equal to the low birthweight risk
advantage of male over female infants (-0.010, 95% CI: -0.011, -0.009).
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Table 3.4: Low birthweight (< 2, 500 grams) effect of maternal blood lead
(1) (2) (3) (4) (5) (6) (7)
LBW LBW LBW LBW LBW LBW LBW
Maternal Blood Lead (µg/dL) 0.009*** 0.020*** 0.009***
(0.001) (0.001) (0.001)
ln Maternal Blood Lead (µg/dL) 0.243*** 0.118***
(0.011) (0.012)
Reference (Maternal Blood Lead Q1)
Maternal Blood Lead Q2 0.017*** 0.004***
(0.001) (0.001)
Maternal Blood Lead Q3 0.028*** 0.007***
(0.001) (0.001)
Maternal Blood Lead Q4 0.040*** 0.010***
(0.002) (0.001)
Maternal Blood Lead Q5 0.067*** 0.016***
(0.004) (0.002)
Constant -0.042*** -0.201*** -0.008 -0.565*** -0.190*** 0.005** 0.098***
(0.008) (0.012) (0.013) (0.029) (0.030) (0.003) (0.007)
Observations 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047
R2 0.003 0.010 0.018 0.010 0.018 0.009 0.018
County FE No Yes Yes Yes Yes Yes Yes
Year FE No Yes Yes Yes Yes Yes Yes
Month FE No Yes Yes Yes Yes Yes Yes
Controls No No Yes No Yes No Yes
Notes: Robust county clustered errors in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1; All models limit to singletons
with plausible gestational length (> 20 weeks); Control variables include: maternal age (1 = Under 20 years of age; 2 =
20-24 years; 3 = 25-29 years; 4 = 30-34 years; 5 = 35-39 years; and 6 = 40-49 years); maternal race (0 = white; 1 =
non-white); maternal education (1 = 0-8 years; 2 = 9-11 years; 3 = 12 years; 4 = 13-15 years; 5 = 16 year and over;
6 = Not stated); interval since last live birth (2 =1-11 months; 3 =12-23 months; 4 =24-35 months; 5 =36-47 months;
6 =48-71 months; 7 =over 72 months; 8 =Not stated); and infant sex (female = 0, male = 1).
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Table 3.5: Very low birthweight (< 1, 500 grams) effect of maternal blood lead
(1) (2) (3) (4) (5) (6) (7)
VLBW VLBW VLBW VLBW VLBW VLBW VLBW
Maternal Blood Lead (µg/dL) 0.002*** 0.004*** 0.002***
(0.000) (0.000) (0.000)
ln Maternal Blood Lead (µg/dL) 0.046*** 0.027***
(0.002) (0.003)
Reference (Maternal Blood Lead Q1)
Maternal Blood Lead Q2 0.003*** 0.001***
(0.000) (0.000)
Maternal Blood Lead Q3 0.005*** 0.001***
(0.000) (0.000)
Maternal Blood Lead Q4 0.008*** 0.002***
(0.000) (0.000)
Maternal Blood Lead Q5 0.013*** 0.003***
(0.001) (0.001)
Constant -0.011*** -0.042*** 0.004 -0.111*** -0.038*** -0.002*** 0.028***
(0.002) (0.002) (0.006) (0.006) (0.010) (0.001) (0.005)
Observations 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047
R2 0.001 0.003 0.006 0.003 0.006 0.003 0.006
County FE No Yes Yes Yes Yes Yes Yes
Year FE No Yes Yes Yes Yes Yes Yes
Month FE No Yes Yes Yes Yes Yes Yes
Controls No No Yes No Yes No Yes
Notes: Robust county clustered errors in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1; All models limit to singletons
with plausible gestational length (> 20 weeks); control variables include maternal age (1 = Under 20 years of age; 2 =
20-24 years; 3 = 25-29 years; 4 = 30-34 years; 5 = 35-39 years; and 6 = 40-49 years); maternal race (0 = white; 1 =
non-white); maternal education (1 = 0-8 years; 2 = 9-11 years; 3 = 12 years; 4 = 13-15 years; 5 = 16 year and over;
6 = Not stated); interval since last live birth (2 =1-11 months; 3 =12-23 months; 4 =24-35 months; 5 =36-47 months;
6 =48-71 months; 7 =over 72 months; 8 =Not stated); and infant sex (female = 0, male = 1)
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Table 3.6: Prematurity (< 37 weeks) effect of maternal blood lead
(1) (2) (3) (4) (5) (6) (7)
Prem Prem Prem Prem Prem Prem Prem
Maternal Blood Lead (µg/dL) 0.011*** 0.028*** 0.010***
(0.001) (0.001) (0.001)
ln Maternal Blood Lead (µg/dL) 0.340*** 0.137***
(0.011) (0.014)
Reference (Maternal Blood Lead Q1)
Maternal Blood Lead Q2 0.026*** 0.006***
(0.001) (0.001)
Maternal Blood Lead Q3 0.042*** 0.010***
(0.001) (0.001)
Maternal Blood Lead Q4 0.059*** 0.014***
(0.002) (0.002)
Maternal Blood Lead Q5 0.096*** 0.021***
(0.003) (0.003)
Constant -0.042*** -0.275*** -0.003 -0.787*** -0.225*** 0.009*** 0.106***
(0.008) (0.014) (0.014) (0.029) (0.037) (0.003) (0.009)
Observations 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047
R2 0.003 0.013 0.024 0.013 0.024 0.011 0.024
County FE No Yes Yes Yes Yes Yes Yes
Year FE No Yes Yes Yes Yes Yes Yes
Month FE No Yes Yes Yes Yes Yes Yes
Controls No No Yes No Yes No Yes
Notes: Robust county clustered errors in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1; All models limit to singletons
with plausible gestational length (> 20 weeks); control variables include maternal age (1 = Under 20 years of age; 2 =
20-24 years; 3 = 25-29 years; 4 = 30-34 years; 5 = 35-39 years; and 6 = 40-49 years); maternal race (0 = white; 1 =
non-white); maternal education (1 = 0-8 years; 2 = 9-11 years; 3 = 12 years; 4 = 13-15 years; 5 = 16 year and over;
6 = Not stated); interval since last live birth (2 =1-11 months; 3 =12-23 months; 4 =24-35 months; 5 =36-47 months;
6 =48-71 months; 7 =over 72 months; 8 =Not stated); and infant sex (female = 0, male = 1)
Notes: Models results depicted are fully saturated with control variables, year, month, and
county fixed effects; All covariates are fixed at sample means; The linear-linear models are
from Column 3, and linear-log models are from Column 4 in Tables 3.4 (for Low Birthweight)
and 3.6 (Prematurity);
Figure 3.4: Predicted low birthweight (< 2, 500 grams) and prematurity (< 37 weeks)
by maternal blood lead
probability of a shortened gestation (< 37 weeks) length by 1 percentage point (95% CI: .008,
.012). In Column 7, we find that the risk of premature birth increases as maternal blood lead
increases from one maternal blood lead quantile to the next, going from 0.006 (Q2) to 0.105 (Q3)
to 0.142 (Q4) to 0.21 (Q5). Other things held equal, infants born to Q5 mothers are 28.96% more
likely than children born to Q1 mothers to be born premature (0.094 vs 0.073).
Next, in Figure 3.4 we graphically summarize results from Table 3.4 and Table 3.6, show-
ing predicted probabilities of low birthweight (< 2, 500 Grams, Panel A) and prematurity (< 37
Weeks, Panel B) by maternal blood lead concentration. In both panels, predictions from linear-
linear and linear-log models are displayed. As shown, the risk of low birthweight and prematurity
increases unmistakably in the maternal blood lead concentration of the birth mother. In going from
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8 to 16 µg/dL, under the linear-linear model, the risk of low birthweight quadruples (0.099 vs
0.025) while the risk of prematurity increases from 3.5 to 13.0 events per 100 live births.
Finally, in Table 3.7 we summarize linear probability models of risk of an infant presenting
with low APGAR score (< 7) in the first minute of life. The APGAR score is a clinical measure of
an infant’s breathing effort, heart rate, muscle tone, reflexes and skin color. An APGAR score of 7
or greater is a sign that a newborn is in good health. As with other birth outcomes, we find that the
risk of a low APGAR score increases significantly in maternal blood lead. In Column 3 showing
results with the full set of controls, we find that a 1 µg/dL increase in maternal blood lead increases
the probability of a mother giving birth to low APGAR score infant by one percentage point (95%
CI: .008, .012). In Column 7, maternal blood lead is divided into quantiles. The probability of
a newborn presenting with a low APGAR score increases incrementally in maternal blood lead
category. Other things held equal, the probability of a very low birthweight event for an infant
born to a Q5 mother is about 20.2% higher than infants born to Q1 infants (0.097 vs 0.081).
Appendix Table C.8 shows results for linear probability models of risk of a newborn presenting
with low APGAR score (< 7) at the five-minute mark of life. Results behave similarly, with the risk
of an abnormal APGAR score at the five-minute mark increasing dose-responsively in maternal
blood lead concentration.
One limitation of the above analysis, regarding the temporal feature of the data, is the po-
tential for the blood lead effect to be overstated due to confounding factors known to negatively
affect birth outcomes. For example, coincidental changes in atmospheric pollutants known to re-
duce birthweight and occurring during the observation period would bias upward the estimated
maternal blood lead effect on this birth outcome. To address this potential source of criticism we
examine data from the NHANESII sample measuring blood Carboxyhemoglobin (COHb) con-
centrations, a bio-marker for carbon monoxide (CO) inhalation. Studies have found ambient CO
concentrations to negatively impact birth outcomes, including reductions in birthweight with the
prevalence of low-birthweight occurrences increasing in atmospheric CO concentrations (Ritz and
Yu, 1999; Maisonet et al., 2001; Salam et al., 2005). Data from respondents in the sample show
that blood COHb concentrations increase year-over-year during our 1976-1980 study period. In-
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Table 3.7: APGAR score (< 7) 1-minute effect of maternal blood lead
(1) (2) (3) (4) (5) (6) (7)
AGAR AGAR AGAR AGAR AGAR AGAR AGAR
Maternal Blood Lead (µg/dL) 0.003*** 0.013*** 0.010***
(0.001) (0.001) (0.001)
ln Maternal Blood Lead (µg/dL) 0.154*** 0.119***
(0.007) (0.013)
Reference (Maternal Blood Lead Q1)
Maternal Blood Lead Q2 0.011*** 0.004***
(0.001) (0.001)
Maternal Blood Lead Q3 0.017*** 0.007***
(0.001) (0.001)
Maternal Blood Lead Q4 0.024*** 0.009***
(0.002) (0.002)
Maternal Blood Lead Q5 0.044*** 0.016***
(0.003) (0.003)
Constant 0.055*** -0.072*** -0.007 -0.297*** -0.183*** 0.064*** 0.100***
(0.010) (0.007) (0.011) (0.019) (0.034) (0.002) (0.003)
Observations 3,852,811 3,852,811 3,852,811 3,852,811 3,852,811 3,852,811 3,852,811
R2 0.000 0.016 0.021 0.016 0.021 0.016 0.021
County FE No Yes Yes Yes Yes Yes Yes
Year FE No Yes Yes Yes Yes Yes Yes
Month FE No Yes Yes Yes Yes Yes Yes
Controls No No Yes No Yes No Yes
Notes: Robust county clustered errors in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1; All models limit to singletons
with plausible gestational length (> 20 weeks); control variables include maternal age (1 = Under 20 years of age; 2 =
20-24 years; 3 = 25-29 years; 4 = 30-34 years; 5 = 35-39 years; and 6 = 40-49 years); maternal race (0 = white; 1 =
non-white); maternal education (1 = 0-8 years; 2 = 9-11 years; 3 = 12 years; 4 = 13-15 years; 5 = 16 year and over;
6 = Not stated); interval since last live birth (2 =1-11 months; 3 =12-23 months; 4 =24-35 months; 5 =36-47 months;
6 =48-71 months; 7 =over 72 months; 8 =Not stated); and infant sex (female = 0, male = 1)
sofar as the inhalation of ambient carbon monoxide is associated with gestational outcomes like
birth weight and risk of low birth weight, our estimates showing an increase in birth weight as a
function of gasoline formulation (that caused a decrease in atmospheric lead) can be interpreted as
conservative.
While it is statistically unlikely that the consistency of results reported above are governed by
chance alone, in the next section we nonetheless perform a series of falsification and robustness
tests. We begin with a falsification exercise involving child sex, an outcome plausibly unrelated to
maternal lead exposure. After that, we examine whether possible compositional effects from the
economic recession in 1980 meaningfully impact parameter estimates of maternal blood lead. We
end with a test that exploits maternal migration during pregnancy, showing that migration decisions
are spatially independent of the concentration in TEL (g/gal) sold to consumers.
3.4.2 Robustness and falsification
With respect to falsification of our maternal blood lead channel, we model an outcome variable
that is unrelated to maternal lead exposure, namely infant sex. We estimate the effect of maternal
lead exposure on sex identity (S) of child i, born at time t in county j with the following linear
probability model:
Sijt = α + β1B̂LLijt + X
′
ijtβ + Γ1Zt + Γ2M t + Γ3Cj + ǫijt (3.10)
where, all terms carry from Equation 3.9, and our outcome variable S is equal to 1 if the newborn
is male and 0 if female. Given that human sex is determined by chromosomal assignment at fer-
tilization, followed by gonadal differentiation and secretion of masculinizing hormones, processes
that operate independently of lead exposure, our statistical expectation of male sex determination
from maternal blood lead is chance indistinguishable or β1 indistinguishable from zero.
Table 3.8 and Figure 3.5 show results from this channel falsification exercise. As expected,
in Table 3.8 we see that whatever the operationalization of maternal blood lead (original units,
log transformed or categorical), the male sex outcome is independent of fetal lead exposure. All
maternal blood lead coefficients are effectively zero. Figure 3.5 graphs predicted probabilities
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Table 3.8: Falsification test of male sex effect of maternal blood lead
(1) (2) (3)
Male Male Male
Maternal Blood Lead (µg/dL) 0.000
(0.000)
ln(Maternal Blood Lead) (µg/dL) -0.000
(0.006)
Reference (Maternal Blood Lead Q1)
Maternal Blood Lead Q2 -0.001
(0.001)
Maternal Blood Lead Q3 -0.001
(0.001)
Maternal Blood Lead Q4 -0.000
(0.001)
Maternal Blood Lead Q5 -0.000
(0.002)
Constant 0.539*** 0.541*** 0.541***
(0.022) (0.027) (0.022)
Observations 6,325,047 6,325,047 6,325,047
R2 0.000 0.000 0.000
County FE Yes Yes Yes
Year FE Yes Yes Yes
Month FE Yes Yes Yes
Controls Yes Yes Yes
Notes: Robust county clustered errors in parentheses *** p < 0.01, ** p < 0.05,
* p < 0.1; All models limit to singletons with plausible gestational length (> 20
weeks); Control variables include: maternal age (1 = Under 20 years of age; 2 = 20-
24 years; 3 = 25-29 years; 4 = 30-34 years; 5 = 35-39 years; and 6 = 40-49 years);
maternal race (0 = white; 1 = non-white); maternal education (1 = 0-8 years; 2 =
9-11 years; 3 = 12 years; 4 = 13-15 years; 5 = 16 year and over; 6 = Not stated);
interval since last live birth (2 =1-11 months; 3 =12-23 months; 4 =24-35 months;
5 =36-47 months; 6 =48-71 months; 7 =over 72 months; 8 =Not stated); and infant
sex (female = 0, male = 1).
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Figure 3.5: Predicted male sex of newborn by maternal blood lead
of male sex from linear (Column 1, Table 3.8) and natural log (Column 2, Table 3.8) models
across various levels of maternal blood lead (µg/dL), confirming our expectation28 of statistical
independence.
Next, we examine whether compositional effects from the economic recession in 1980 mean-
ingfully impact parameter estimates of maternal blood lead. Recessions have known income and
opportunity cost effects on reproductive choice, functioning on net to increase the average human
capital and socioeconomic status of birth mothers. Between 1977-1979 (pre-recession) and 1980
(recession), we observe decreases in the percentage of birth mothers with less than a high school
degree, percentage non-white mothers, and the percentage of teen mothers, as well as increases in
the percentage of birth mothers with a college degree. While previous models have year and month
fixed effects, given compositional change in birth mothers toward lower risk of lead exposure, pre-
vious estimates on maternal blood lead may be understated. Appendix Section B details the logic.
28While results behave as expected, there is a possible indirect theoretical link between that maternal blood lead
and male sex. Supposing that maternal lead exposure increases the risk of fetal mortality, and given that the risk of
fetal demise is higher in male versus female unborn, primary sex ratios can depart from standard expectation. This
indirect pathway implies a negative association between maternal blood lead and probability of male infant sex. To
our knowledge, no study has convincingly linked lead exposure to differential demise by fetal sex.
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We estimate the following linear probability model, where Rt denotes the two birth outcomes of
infant birth weight and gestational age:




X ′ijtβ + Γ1M t + Γ2Cj + ǫijt (3.11)
where, again, terms carry from Equation 3.9 with the exception of Rt that is equal to 1 if the birth
event occurred in 1980, and zero otherwise. Of theoretical interest is the δ parameter, capturing
the interaction effect of maternal blood lead and economic recession of 1980.
Table 3.9 shows results for linear probability models of the infant birthweight and gestational
length effects of maternal blood lead interacted with the 1980 economic recession. As before,
interpretive emphasis is on fully saturated linear-linear models in columns 3 (birth weight) and
7 (gestation length). With respect to birthweight, we find that the negative effect of maternal
blood lead worsened in the 1980 recession, evident in the negative sign on the interaction term
(β̂ = -6.28). The same is true of gestation length, with the negative effect of maternal blood lead
amplifying in the recession (β̂ = -0.019). The combined effects of the maternal blood lead and
interaction with recession indicator are approximately equal to main effects reported in Tables 3.2
and 3.3, corresponding to birthweight and gestation length, respectively. Figure 3.6 traces the dif-
ferential response in birth outcomes to maternal blood lead dosage. Other things held equal, and
focusing on linear-linear model results, in Panel A showing predicted birthweight in grams we find
that infants born in the economic recession to mothers with 16 µg/dL, for instance, weighted on av-
erage about 52.96 grams less than the same children before the recession (3,255.63g vs 3,308.59g).
Similarly, in Panel B showing predicted gestation length in weeks we find that infants born in the
economic recession to mothers with 16 µg/dL, for instance, realized pregnancy lengths that were
1.35 days shorter than like children before the recession (39.23 vs 39.43 weeks).
All together, these results on the amplification effect of the economic recession are indicative
of co-variation of maternal blood lead and unmeasured demographic characteristics of mothers
that are correlated with negative birth outcomes.
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Table 3.9: Birthweight (grams) and gestation length effects of maternal blood lead by 1980 recession
(1) (2) (3) (4) (5) (6) (7) (8)
BW BW BW BW GL GL GL GL
Maternal Blood Lead (µg/dL) -48.598*** -65.279*** -13.570*** -0.184*** -0.248*** -0.042***
(3.344) (3.504) (1.479) (0.012) (0.010) (0.006)
Recession (1980) 76.417*** 148.203*** 47.480*** 68.618*** 0.274*** 0.543*** 0.113** 0.190*
(12.237) (10.862) (8.282) (19.300) (0.048) (0.053) (0.047) (0.109)
Maternal Blood Lead × Recession -15.168*** -25.604*** -6.277*** -0.061*** -0.100*** -0.019***
(1.132) (0.974) (0.920) (0.004) (0.005) (0.005)
ln Maternal Blood Lead (µg/dL) -177.065*** -0.570***
(18.106) (0.076)
ln Maternal Blood Lead × Recession -38.591*** -0.125**
(8.817) (0.049)
Constant 3,943.391*** 4,176.144*** 3,314.661*** 3,593.206*** 41.790*** 42.708*** 40.056*** 40.981***
(36.969) (43.642) (25.665) (48.956) (0.127) (0.128) (0.195) (0.262)
Observations 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047
R2 0.012 0.029 0.069 0.069 0.008 0.017 0.027 0.027
County FE No Yes Yes Yes No Yes Yes Yes
Month FE No Yes Yes Yes No Yes Yes Yes
Controls No No Yes Yes No No Yes Yes
Notes: Robust county clustered errors in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1; All models limit to singletons with plausible gestational
length (> 20 weeks); Control variables include: maternal age (1 = Under 20 years of age; 2 = 20-24 years; 3 = 25-29 years; 4 = 30-34 years; 5 =
35-39 years; and 6 = 40-49 years); maternal race (0 = white; 1 = non-white); maternal education (1 = 0-8 years; 2 = 9-11 years; 3 = 12 years; 4 =
13-15 years; 5 = 16 year and over; 6 = Not stated); interval since last live birth (2 =1-11 months; 3 =12-23 months; 4 =24-35 months; 5 =36-47
months; 6 =48-71 months; 7 =over 72 months; 8 =Not stated); and infant sex (female = 0, male = 1).
Figure 3.6: Predicted birthweight and gestation length by maternal blood lead
and 1980 recession
Of the 6,325,047 birth events satisfying our inclusion criteria, just shy of 184,000 had a re-
ported state of residence different from the state of birth occurrence. Because leaded-gasoline was
phased-out differently by states in time, the movement of these mothers is potentially exploitable
as a natural experiment in TEL exposure. Toward this end, we present evidence showing that: 1)
∆TEL = TELoccurrence − TELresidence is a standard normal variable; and 2) mothers moving
from higher to a lower TEL environment are statistically similar to mothers moving from a lower
to a higher TEL environment.
Taking the TEL (g/gal) difference at the place of birth occurrence and place of residence, we
derive whether a mother moved up or down in TEL exposure risk to birth her child and the precise
change in TEL exposure. Although the distance moved from place of residence to place of birth
occurrence was highly positively skewed, as moving mothers were substantially more likely to
travel shorter than longer distances, the distribution of ∆TEL had near zero skew (S = 0.227).
Figure 3.7 is a histogram of migrating mothers on state of residence (TEL g/gal) versus state of
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Notes: All other covariates fixed at means.
Figure 3.7: Histogram of migrating mothers on state of residence (TEL g/gal) versus
state of birth occurrence (TEL g/gal)
birth occurrence (TEL g/gal). The distribution of ∆TEL is modestly leptokurtic (Kurtosis =
5.744), with µ = 0.006, σ = 0.149.
Second, on the observed risk factors of deleterious birth outcomes, up- and down-moving moth-
ers are statistically similar with respect to the change in TEL exposure risk. Consider Table 3.10
comparing up-moving and down-moving mothers on the probability of up-moving in TEL ex-
posure risk. Limiting to moving mothers only, we regressed up-moving status (1 = up-moving
mother; 0 = down-moving mother) on relevant covariates of birth outcomes. If movement-caused
TEL exposure risk is a pseudo-randomly assigned, then we ought to see no meaningful differences
between up-moving and down-moving mothers on the determinants of birth outcomes with respect
to up-moving in TEL exposure risk. All coefficients on covariates of interests in Table 3.10 are
chance indistinguishable, supporting the notion that maternal up versus down movement in TEL
exposure risk is a quasi-random process. Mothers made migration decisions independent of the
concentration in TEL (g/gal) sold to consumers.
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Table 3.10: Linear probability model coefficients of maternal up-movement in TEL exposure
among moving mothers
∆ TEL > 0 ∆ TEL > 0
Reference = January Reference = Maternal Age < 20 years
February -0.005 20-24 years -0.002
(0.004) (0.004)
March -0.004 25-29 Years -0.003
(0.004) (0.008)
April -0.005 30-34 years -0.007
(0.006) (0.010)
May 0.001 35-39 years -0.004
(0.005) (0.012)
June -0.001 40-49 years -0.019
(0.004) (0.011)
July -0.005 Reference = Birth Interval (No Previous)
(0.004)
August -0.003 1-11 months -0.019
(0.004) (0.012)
September -0.004 12-23 months 0.003
(0.004) (0.005)
October -0.005 24-35 months 0.006
(0.004) (0.005)
November -0.002 36-47 months 0.003
(0.004) (0.006)
December -0.004 48-71 months 0.001
(0.004) (0.006)
Reference = 1977 > 72 months 0.010
(0.009)
Year 1978 -0.033 Not stated -0.017
(0.099) (0.020)
Year 1979 0.044 Reference = Female
(0.081)
Year 1980 0.014 Male infant 0.001
(0.081) (0.002)
Reference = Education (Not Applicable) Reference = Non-Minority




12 years -0.192 (0.304)
(0.313)
13-15 years -0.200 Observations 183,605
(0.313) R2 0.532




Notes: Robust county clustered errors in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1; All models limit to
singletons with plausible gestational length (> 20 weeks).
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Insofar as observable and unobservable maternal and infant characteristics are correlated (i.e.,
the proportionality assumption), and assuming that the proportion of time spent in the state of birth
occurrence versus the state of residence is statistically independent of whether a mother moves
up or down in TEL exposure, then we ought to see a worsening in birth outcomes as ∆TEL
increases. The effect of TEL exposure is estimated with the following model:
Bijt = α + β1∆TELijt + β2MVit + X
′
ijtβ + Γ1Zt + Γ2M t + Γ3Cj + ǫijt (3.12)
where, all terms from Equation 3.9 carry, with the exception of ∆TELijt measured as
TELoccurrence − TELresidence, and MVit which an indicator variable equal to 1 if the mother
birthed her infant in a state different from her state of residence. The coefficient of analytic interest
is β1 reflecting the effect of the change in TEL exposure on various birth outcomes. The expec-
tation is that β1 is negative for birthweight (grams) and gestation length (weeks), and positive for
dichotomous outcomes like low birthweight, very low birthweight, prematurity, and low APGAR
score.
Table 3.11 reports results. Other things equal, in Column 1 we find that a 1 g/gal increase in
∆TEL exposure decreases infant birthweight by just shy of 60 grams (95% CI: -99.21, -20.41).
In Column 2, we find that gestation length decreases by 0.278 weeks (or about 2 days) for a unit
increase in ∆TEL. The probability of low birthweight (< 2, 500 grams), very low birthweight
(< 1, 500 grams), and premature birth (< 37 weeks) increase 2.6 percentage points, eight-tenths of
one percentage points, and 3.1 percentage points, respectively, as ∆TEL increases 1 g/gal. Also
noteworthy is that moving mothers, as compared to non-moving mothers, deliver infants that are
lighter, that are more likely to be of low and very low birthweight status, and are more likely to be
born prematurely.
Finally, Figure 3.8 summarizes results in Table 3.11, showing predicted birthweight and ges-
tation length in Panel A, and predicted low and very low birthweight status in Panel B for unit
changes in ∆TEL. For all predictions, other model covariates are fixed at sample means. Fo-
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Table 3.11: Birth outcome effects of maternal TEL exposure through migration
(1) (2) (3) (4) (5)
Birthweight(g) Gestation(w) LBW (<2,500g) VLBW (1,500g) Premature(<37w)
TEL ∆ (g/gal) -59.810*** -0.278*** 0.026*** 0.008** 0.031***
(20.091) (0.095) (0.010) (0.004) (0.009)
Mover -20.417*** -0.142*** 0.011*** 0.006*** 0.013***
(4.698) (0.022) (0.002) (0.001) (0.002)
Constant 3,144.834*** 39.538*** 0.108*** 0.030*** 0.121***
(16.723) (0.198) (0.007) (0.005) (0.011)
Observations 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047
R2 0.069 0.027 0.018 0.006 0.024
County FE Yes Yes Yes Yes Yes
Year FE Yes Yes Yes Yes Yes
Month FE Yes Yes Yes Yes Yes
Controls Yes Yes Yes Yes Yes
Notes: Robust county clustered errors in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1; All models
limit to singletons with plausible gestational length (> 20 weeks); control variables include maternal
age (1 = Under 20 years of age; 2 = 20-24 years; 3 = 25-29 years; 4 = 30-34 years; 5 = 35-39 years;
and 6 = 40-49 years); maternal race (0 = white; 1 = non-white); maternal education (1 = 0-8 years;
2 = 9-11 years; 3 = 12 years; 4 = 13-15 years; 5 = 16 year and over; 6 = Not stated); interval since last
live birth (2 =1-11 months; 3 =12-23 months; 4 =24-35 months; 5 =36-47 months; 6 =48-71 months;
7 =over 72 months; 8 =Not stated); and infant sex (female = 0, male = 1)
cusing on Panel B, a 1 g/gal increase in ∆TEL from zero increases the risk of low birthweight
by 38.8% (0.067 versus 0.093 probability) and the risk of very low birthweight by 57.1% (0.014
versus 0.022 probability).
3.5 Discussion and conclusion
Exploiting natural experiments in the spatial and temporal distribution of maternal exposure
arising from the differential phase-out of leaded gasoline across states, and the independent migra-
tion behavior of mothers during pregnancy, we find considerable evidence that fetal exposure to
lead through the maternal blood lead pathway significantly compromises infant health. Across an
ensemble of tests, we find that an increase in maternal blood lead: 1) decreases infant birthweight;
2) increases the risk of low and very low birthweight; 3) shortens gestation length; 4) increases
the risk of prematurity; and 5) increases the risk of a low APGAR score. These results are ro-
bust to various operations of our treatment variable – whether measured in original units (µg/dL),
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Notes: All other covariates fixed at means.
Figure 3.8: Predicted birthweight (grams), gestation length (weeks), low birthweight
status (< 2, 500 grams), and prematurity (< 37 weeks) by difference of state of resi-
dence (TEL g/gal) versus state of birth occurrence (TEL g/gal) of migrating mothers
log transformed, or divided in quantiles – and the relaxation of inclusion criteria to birth events
in all states irrespective of the universality of reporting, accounting for possible fertility selection
effects through the 1980 economic recession, and the substitution of our treatment variable of ma-
ternal blood lead for concentration (g/gal) exposure. Moreover, we satisfied a divergent validity
test by falsifying our causal channel of maternal blood lead with analyses of the lead-independent
outcome of infant sex.
Taken together, these results suggest considerable social and economic benefits from the phase-
out of leaded gasoline in the United States through improved infant health. To gauge these gains,
first consider the sizable ex-ante estimated social and economic benefits of the phase-out of lead
in paint. According to Gould (2009), each dollar invested in lead paint hazard control delivered
a return of $17-221 and hundreds of billions in net savings. These benefits were realized through
reductions in health care costs, special education costs, and costs of psychological disorders, as
99
well as by increased lifetime earnings of children through significant cognitive gains. Because
leaded gasoline was a far more important determinant of lead exposure in the United States in the
second half of the 20th Century (see Laidlaw and Filippelli (2008)), the phase-out as a constituent
in automotive gasoline likely delivered benefits on par or in excess of what was had from lead paint
hazard control efforts.
In Table 3.12 we calculate the economic benefits of the phase-out of leaded gasoline through
the reduction of healthcare-related costs involved in treating low birthweight infants. Importantly,
healthcare-related costs of low birthweight constitute a fraction29 of the total costs of maternal
and infant lead exposure over the life-course. To capture our slice of costs, we first estimate the
conditional probability P (LBW ) of a child being born at less than 2,500 grams as well as the
complement probability of normal birthweight P in 1977, 1980, and 1987, given a maternal blood
lead (µg/dL) level and leveraging the coefficient on maternal blood lead vis-á-vis low birthweight
risk in Table 3.4, Column 3.
Three scenarios (S) are presented, involving assumptions about the healthcare-related costs (C)
of normal birthweight (NBW ), low birthweight (LBW ) at birth (Lewit et al., 1995; Almond et al.,
2005) and costs of a LBW infant till age 15 (Lewit et al., 1995). To get the expected healthcare-
related costs per infant (EC) we calculate: EC = P (NBW ) × CNBW + P (LBW ) × CLBW .
Across the three scenarios, the healthcare-related costs of a NBW infant is assumed to be $3,432
(Lewit et al., 1995). In the first scenario, healthcare-related costs at birth of LBW is assumed to be
$27,095 (Lewit et al., 1995), in the second $25,750 (Almond et al., 2005), and in the third scenario
healthcare-related costs of a LBW infant till age 15 is $89,975 (Lewit et al., 1995). All figures
are in 1999 USD. Assuming 4 million births annually and an expected cost of per infant (EC) of
$5,017 (S1), $4,927 (S2) and $9,230 (S3), total annual healthcare-related costs of live-births are
$21.1, $19.7, and $36.9 billion in 1977, respectively. By 1980, following from a rapid reduction
in the concentration of TEL in gasoline nationwide, total annual healthcare-related costs of live-
29In Gould’s (2009) assessment of the benefits of lead paint hazard control, health care costs are between 6 and 20%
of the total net savings (involving other dimensions of life earnings, tax revenue, special education, attention deficit-
hyperactivity disorder, and the direct costs of crime). Also, studies find that maternal exposure to lead increases the
risk of hypertensive disorders like eclampsia (Zahran et al., 2014).
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Table 3.12: Estimated savings from low birthweight from the phase-out of leaded gasoline
Maternal Blood Expected ∆ Cost % Cost Annual Savings
Year Lead (µg/dL) P(LBW) P(NBW) Cost from 1977 from 1977 ($ Billions)‡‡
1977 12.56 0.067 0.933 $5,017
1980 10.15 0.043 0.957 $4,450 -$568 -11.32% $2.27
1987 8.500∗ 0.029‡ 0.971 $4,118 -$899 -17.92% $3.60
Costs at Birth
$27,095†
1977 12.56 0.067 0.933 $4,927
1980 10.15 0.043 0.957 $4,392 -$536 -10.87% $2.14
1987 8.500∗ 0.029‡ 0.971 $4,079 -$848 -17.21% $3.39
Cost at Birth
$25,750††
1977 12.56 0.067 0.933 $9,230
1980 10.15 0.043 0.957 $7,153 -$2,077 -22.50% $8.31
1987 8.500∗ 0.029‡ 0.971 $5,942 -$3,289 -35.63% $13.16
Costs <15 years
$89,975†
Notes: Healthcare-related costs of a non-low birth weight (NLBW) infant is assumed to be $3,432 and from
Lewit et al. (1995); †Healthcare-related costs of low birthweight (LBW) till age 15 and at birth are from Lewit
et al. (1995); ††Healthcare-related costs of LBW at birth are from Almond et al. (2005); Mean maternal
blood lead is limited to mothers birthing singletons with plausible gestational age from states with complete
reporting; ∗Estimated blood lead of mothers in 1987 is derived from the statistical relationship of blood lead
and TEL concentration, anchored on the observed TEL concentration in 1987 of 0.10 g/gal; The estimated
fraction of low birthweight infants in 1987 leverages the coefficient on maternal blood lead vis-á-vis low
birthweight risk in Table 3.4, Column 3; To get the expected healthcare-related costs per infant (EC) we
calculate: EC = P (NWB) × CNBW + P (LBW ) × CLBW ;
‡‡To get total savings, we multiply EC by an
assumed 4 million births per year in the United States;
births decreased by an estimated $2.1 (at birth) to $8.3 billion (by age 15). By 1987, when leaded
gasoline was largely phased-out, annual savings reach $3.4 (at birth) to $13.2 billion (by age 15).
In 2019 USD, total healthcare-related savings from 1987 to the present exceed $150 billion (at
birth) to $600 billion by age 15.
The foregoing benefit analysis adds to the measured gains amassed from lead hazard control
policies, detailing yet another channel by which lead destroys human potential and societal wel-
fare. While the elimination of leaded gasoline substantially reduced the flow of lead into the lived
environment, both stock and flow sources of exposure risk remain in the United States and abroad.
These sources present an ongoing risk to infant health.
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Appendix A
Risk assessment question set, NLSY97
To characterize individual’s appetite for risk, respondents were given a set of nine questions,
and asked to rate their willingness to take risks in a given context. The lead in question reads:
Are you generally a person who is fully prepared to take risks or do you try to avoid
taking risks? Rate yourself from 0 to 10, where 0 means “unwilling to take any risks”
and 10 means “fully prepared to take risks.”
After responding to the previous question, respondents are read the following statement:
People can behave differently in different situations. How would you rate your will-
ingness to take risks in the following areas? For each situation, rate yourself from 0 to
10, where 0 means “unwilling to take any risks” and 10 means “fully prepared to take
risks.”
then asked to answer the following sequence of risk assessment questions, in order:
1. “...While driving?”
2. “...In financial matters?”
3. “...In your occupation?”
4. “...With your health?”
5. “...In your faith in other people?”
6. “...In your romantic relationships?”
7. “...In making major life changes?”




Recession effect on maternal blood lead
To elucidate how an economic recession may implicate the estimated effect of maternal blood
lead on infant birthweight through selection of birth mothers, let E(BW |Pb, s) be the expected
birthweight (BW ) on an infant given maternal blood lead (Pb) and socioeconomic status (s). This
is a physiological relationship which won’t be affected by an embargo or recession.
Letting f0(s) be the probability density function (pdf) of the socio-economic factors (SEF) of
women who give birth before the event, and f1(s) the pdf of SEF women who give birth after the
event.
Assume that s ∈ [0, S]. We expect higher SEF women to be more likely to give birth after an
event. So, f1(•) will stochastically dominate f0(•) (i.e. F0(s) ≥ F1(s) ∀ s, and Fj(•) ∀ j ∈ {1, 2}
is the cumulative distribution function (cdf) of the pdf’s).
The BW-Pb relationship in the period before is BW0(Pb) =
S∫
0
E(BW |Pb, s) · f0(s) ds
The BW-Pb relationship in the period after is BW1(Pb) =
S∫
0
E(BW |Pb, s) · f1(s) ds











E(BW |Pb, s) · f0(s) ds (B.1)
Focusing on the first component in the right-hand side of Equation B.1 and using Integration




E(BW |Pb, s) · f1(s) ds =
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Combining Equation B.2 and Equation B.3, we get:
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Because we expect socio-economic factors to have a positive impact on birthweight,
∂ E(BW |Pb,s)
∂ s
> 0. Furthermore, if f1(s) stochastically dominates f0(s), then[
F0(s) − F1(s)
]




Table C.1: Blood lead effect of average gasoline lead concentrations, Reyes (2015) replication
(1) (2) (3) (4) (5) (6)
Gasoline Lead (g/gal) 4.17*** 6.73*** 4.39* 5.73** 4.56* 8.67*
(1.285) (1.186) (2.438) (2.211) (2.565) (4.651)
Age -0.27** -0.27** -0.29** -0.34*** -0.30** -0.38
(0.124) (0.128) (0.123) (0.126) (0.125) (0.445)
Female -0.53** -0.46* -0.44 -0.52* -0.48* -0.27
(0.256) (0.261) (0.264) (0.287) (0.256) (0.355)
Black 6.84*** 6.58*** 6.41*** 7.08*** 6.38***
(0.833) (0.647) (0.602) (0.638) (0.994)
Low 1.82*** 1.77*** 1.78*** 2.70*** 1.95***
(0.414) (0.370) (0.373) (0.487) (0.663)
Mid -0.41 -0.44 -0.47 -0.73* -0.53
(0.458) (0.398) (0.393) (0.403) (0.647)
Constant 8.26*** 1.06 8.64* 7.63* 9.15* 2.50
(2.365) (2.171) (4.795) (4.482) (4.946) (9.718)
Observations 2,192 2,192 2,192 2,192 2,192 833
R2 0.216 0.285 0.295 0.218 0.280 0.386
State FE No Yes Yes Yes Yes Yes
Month FE Yes Yes Yes Yes Yes Yes
Year FE No No Yes Yes Yes Yes
Ages 0-6 0-6 0-6 0-6 0-6 2-4
Notes: Results are a replication of Reyes (2015), Table 3; Dependent variable is
blood lead level (BLL) in µg/dL; Robust state clustered errors in parentheses ***
p < 0.01, ** p < 0.05, * p < 0.1; Gasoline lead is TEL concentrations (g/gal);
Age is respondent’s age (years) when the survey was conducted; Indicators for sex
and racial status are defined as Female=1, and Black=1 if the respondent identifies
as African American; Indicators for household income relative to Federal Poverty
Level (FPL) are: Low=1 for < 2x FPL and Mid=1 for ratios ≤2x FPL and <3x FPL;
State of residence, and Year and Month of survey fixed effects are included as noted;
Regression inclusion criteria denoted by Age group;
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Table C.2: IQ and low-IQ effect of blood lead by quintiles, linear regressions
(1) (2) (3) (4) (5) (6)
IQ Percentile IQ Percentile IQ Percentile Low-IQ Low-IQ Low-IQ
Blood Lead (µg/dL, Q1 Reference Group)
Blood Lead Q2 -0.061*** -0.060*** -0.031** 0.093*** 0.091*** 0.050*
(0.013) (0.013) (0.015) (0.023) (0.024) (0.026)
Blood Lead Q3 -0.103*** -0.101*** -0.038** 0.151*** 0.149*** 0.064**
(0.013) (0.013) (0.017) (0.024) (0.024) (0.029)
Blood Lead Q4 -0.143*** -0.141*** -0.062*** 0.223*** 0.221*** 0.113***
(0.019) (0.019) (0.019) (0.033) (0.033) (0.037)
Blood Lead Q5 -0.213*** -0.210*** -0.097*** 0.319*** 0.317*** 0.162***
(0.023) (0.022) (0.026) (0.043) (0.043) (0.046)
Poverty Ratio (Q1 Reference Group)
Poverty Ratio Q2 0.073*** -0.122***
(0.016) (0.019)
Poverty Ratio Q3 0.139*** -0.200***
(0.012) (0.021)
Poverty Ratio Q4 0.203*** -0.256***
(0.016) (0.024)
Constant 0.599*** 0.604*** 0.446*** 0.073 0.069 0.288***
(0.024) (0.024) (0.022) (0.050) (0.049) (0.054)
Observations 4,587 4,587 4,587 4,587 4,587 4,587
R2 0.224 0.225 0.276 0.178 0.178 0.211
State FE Yes Yes Yes Yes Yes Yes
Cohort FE Yes Yes Yes Yes Yes Yes
Oversample FE Yes Yes Yes Yes Yes Yes
Notes: Dependent variables are percentile score on ASVAB examination and low-IQ (<25th percentile) indicator. Robust
state clustered errors in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1. Blood lead quintiles are NLSY sample weighted
and using predicted mean blood lead in µg/dL. Poverty ratio quartiles are based on household income to poverty ratio,
1997 (survey round one). State of residence and cohort fixed effects are included in regressions. Controls for sex, minority
status, and prior ASVAB excluded for clarity.
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Table C.3: Abnormal risk response effects of blood lead, statistically significant models and coefficients
(1) (2) (3) (4) (5) (6)
Drive Finance Work Health Romance Gamble
Blood Lead (µg/dL) 0.021* 0.023*** 0.029*** 0.034* 0.017** 0.024**
(0.011) (0.008) (0.008) (0.019) (0.009) (0.012)
Sex 0.047 0.124*** 0.047 -0.081 0.073** 0.054*
(0.032) (0.028) (0.030) (0.049) (0.032) (0.031)
Minority 0.140*** 0.114** 0.073* 0.272*** 0.035 -0.021
(0.050) (0.044) (0.043) (0.068) (0.036) (0.046)
Married -0.047 -0.022 0.038 -0.020 0.134*** 0.025
(0.030) (0.028) (0.034) (0.057) (0.033) (0.033)
Poverty Ratio (Q1 Reference Group)
Poverty Ratio Q2 -0.052 -0.116*** -0.067* -0.115 -0.065* -0.123**
(0.039) (0.038) (0.036) (0.069) (0.035) (0.052)
Poverty Ratio Q3 -0.116** -0.139*** -0.042 -0.102 -0.003 -0.035
(0.045) (0.028) (0.043) (0.078) (0.033) (0.042)
Poverty Ratio Q4 -0.121** -0.139*** -0.134*** -0.357*** -0.108*** -0.048
(0.050) (0.040) (0.048) (0.092) (0.037) (0.043)
Constant 0.613*** 0.291*** 0.333*** 0.144 0.737*** 0.736***
(0.120) (0.107) (0.107) (0.237) (0.108) (0.126)
Observations 4,224 4,224 4,224 4,224 4,224 4,224
R-squared 0.040 0.046 0.033 0.044 0.031 0.019
State FE Yes Yes Yes Yes Yes Yes
Cohort FE Yes Yes Yes Yes Yes Yes
Oversample FE Yes Yes Yes Yes Yes Yes
Notes: Dependent variables are abnormal risk preferences (mean deviation), based on NLSY97 survey re-
sponses; Robust state clustered errors in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1; Blood lead
is predicted mean blood lead in µg/dL; Indicators controlling for for sex (Sex=1 if male), minority status
(Minority=1, if non-white), and marital status (Married=1 if married when surveyed); Poverty ratio quartiles
are based on household income to FPL poverty ratios; State of residence, age cohort, and over-sample survey
group fixed effects included in all regressions;
Table C.4: Birthweight (grams) effect of TEL
(1) (2) (3) (4) (5)
BW BW ln(BW) BW ln(BW)
TEL (g/gal) -11.506***
(1.278)
ln(TEL) (g/gal) -13.394*** -0.004***
(1.356) (0.000)
Reference TEL (g/gal) Q1
TEL (g/gal) Q2 -8.461*** -0.003***
(1.112) (0.000)
TEL (g/gal) Q3 -10.022*** -0.003***
(1.147) (0.000)
TEL (g/gal) Q4 -10.230*** -0.003***
(1.177) (0.000)
TEL (g/gal) Q5 -13.663*** -0.004***
(1.416) (0.000)
Constant 3,159.524*** 3,147.277*** 8.023*** 3,152.386*** 8.024***
(16.481) (16.451) (0.007) (16.582) (0.007)
Observations 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047
R2 0.069 0.069 0.057 0.069 0.057
County FE Yes Yes Yes Yes Yes
Month FE Yes Yes Yes Yes Yes
Controls Yes Yes Yes Yes Yes
Notes: Robust county clustered errors in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1;
All models limit to singletons with plausible gestational length (> 20 weeks); control variables
include maternal age (1 = Under 20 years of age; 2 = 20-24 years; 3 = 25-29 years; 4 = 30-
34 years; 5 = 35-39 years; and 6 = 40-49 years); maternal race (0 = white; 1 = non-white);
maternal education (1 = 0-8 years; 2 = 9-11 years; 3 = 12 years; 4 = 13-15 years; 5 = 16
year and over; 6 = Not stated); interval since last live birth (2 =1-11 months; 3 =12-23 months;
4 =24-35 months; 5 =36-47 months; 6 =48-71 months; 7 =over 72 months; 8 =Not stated); and
infant sex (female = 0, male = 1).
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Table C.5: Birthweight (grams) effect of Pb gasoline emissions
(1) (2) (3) (4) (5)
BW BW ln(BW) BW ln(BW)
Pb Emissions -3.055
(0.274)
ln(Pb Emissions) -12.613*** -0.004***
(1.197) (0.000)
Reference Pb Emissions Q1
Pb Emissions Q2 -7.543*** -0.002***
(1.579) (0.001)
Pb Emissions Q3 -8.527*** -0.002***
(2.228) (0.001)
Pb Emissions Q4 -16.019*** -0.005***
(2.185) (0.001)
Pb Emissions Q5 -21.585*** -0.006***
(2.375) (0.001)
Constant 3,152.221*** 3,246.911*** 8.051*** 3,151.932*** 8.024***
(16.664) (19.558) (0.008) (16.418) (0.007)
Observations 6,325,047 6,325,047 6,325,047 6,325,047 6,325,047
R2 0.069 0.069 0.057 0.069 0.057
County FE Yes Yes Yes Yes Yes
Month FE Yes Yes Yes Yes Yes
Controls Yes Yes Yes Yes Yes
Notes: Robust county clustered errors in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1; All
models limit to singletons with plausible gestational length (> 20 weeks); control variables include
maternal age (1 = Under 20 years of age; 2 = 20-24 years; 3 = 25-29 years; 4 = 30-34 years; 5 =
35-39 years; and 6 = 40-49 years); maternal race (0 = white; 1 = non-white); maternal education
(1 = 0-8 years; 2 = 9-11 years; 3 = 12 years; 4 = 13-15 years; 5 = 16 year and over; 6 =
Not stated); interval since last live birth (2 =1-11 months; 3 =12-23 months; 4 =24-35 months;
5 =36-47 months; 6 =48-71 months; 7 =over 72 months; 8 =Not stated); and infant sex (female
= 0, male = 1); Pb emissions are mesured in tonnages/1000.
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Table C.6: Birthweight (grams) effect of maternal blood lead, all states
(1) (2) (3) (4) (5) (6) (7) (8) (9)
BW BW BW BW ln(BW) ln(BW) BW BW BW
Maternal Blood Lead (µg/dL) -36.638*** -79.675*** -22.192***
(2.311) (3.511) (2.072)
ln(Maternal Blood Lead) (µg/dL) -304.168*** -0.331*** -0.120***
(20.615) (0.013) (0.006)
Reference (Maternal Blood Lead Q1)
Maternal Blood Lead Q2 -7.856*** -67.581*** -13.687***
(1.537) (2.756) (1.913)
Maternal Blood Lead Q3 -19.875*** -112.779*** -25.662***
(2.159) (4.438) (3.019)
Maternal Blood Lead Q4 -42.157*** -157.387*** -36.636***
(4.548) (5.880) (4.415)
Maternal Blood Lead Q5 -150.129*** -269.674*** -52.293***
(7.909) (10.592) (5.088)
Constant 3,787.969*** 4,402.354*** 3,514.070*** 4,005.595*** 8.955*** 8.368*** 3,409.278*** 3,573.915*** 3,273.031***
(23.388) (46.377) (28.719) (53.568) (0.033) (0.017) (3.147) (8.416) (5.865)
Observations 8,568,194 8,568,194 8,568,194 8,568,194 8,568,194 8,568,194 8,568,194 8,568,194 8,568,194
R2 0.009 0.029 0.068 0.068 0.026 0.057 0.009 0.025 0.068
County FE No Yes Yes Yes Yes Yes No Yes Yes
Year FE No Yes Yes Yes Yes Yes No Yes Yes
Month FE No Yes Yes Yes Yes Yes No Yes Yes
Controls No No Yes Yes No Yes No No Yes
Notes: Robust county clustered errors in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1; All models limit to singletons with plausible gestational length (> 20 weeks);
control variables include maternal age (1 = Under 20 years of age; 2 = 20-24 years; 3 = 25-29 years; 4 = 30-34 years; 5 = 35-39 years; and 6 = 40-49 years); maternal race
(0 = white; 1 = non-white); maternal education (1 = 0-8 years; 2 = 9-11 years; 3 = 12 years; 4 = 13-15 years; 5 = 16 year and over; 6 = Not stated); interval since last live
birth (2 =1-11 months; 3 =12-23 months; 4 =24-35 months; 5 =36-47 months; 6 =48-71 months; 7 =over 72 months; 8 =Not stated); and infant sex (female = 0, male
= 1).
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Table C.7: Gestational length (weeks) effect of maternal blood lead, all states
(1) (2) (3) (4) (5) (6) (7) (8) (9)
GL GL GL GL ln(GL) ln(GL) GL GL GL
Maternal Blood Lead (µg/dL) -0.130*** -0.313*** -0.097***
(0.008) (0.010) (0.007)
ln(Maternal Blood Lead) (µg/dL) -1.338*** -0.105*** -0.038***
(0.077) (0.003) (0.002)
Reference (Maternal Blood Lead Q1)
Maternal Blood Lead Q2 -0.025*** -0.300*** -0.064***
(0.005) (0.008) (0.007)
Maternal Blood Lead Q3 -0.063*** -0.491*** -0.111***
(0.007) (0.012) (0.011)
Maternal Blood Lead Q4 -0.154*** -0.677*** -0.150***
(0.014) (0.016) (0.015)
Maternal Blood Lead Q5 -0.534*** -1.093*** -0.226***
(0.028) (0.024) (0.019)
Constant 41.088*** 43.730*** 40.870*** 43.040*** 3.947*** 3.773*** 39.738*** 40.530*** 39.808***
(0.078) (0.132) (0.095) (0.201) (0.007) (0.006) (0.011) (0.020) (0.027)
Observations 8,568,194 8,568,194 8,568,194 8,568,194 8,568,194 8,568,194 8,568,194 8,568,194 8,568,194
R2 0.005 0.018 0.027 0.027 0.018 0.027 0.005 0.016 0.026
County FE No Yes Yes Yes Yes Yes No Yes Yes
Year FE No Yes Yes Yes Yes Yes No Yes Yes
Month FE No Yes Yes Yes Yes Yes No Yes Yes
Controls No No Yes Yes No Yes No No Yes
Notes: Robust county clustered errors in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1; All models limit to singletons with plausible gestational
length (> 20 weeks); control variables include maternal age (1 = Under 20 years of age; 2 = 20-24 years; 3 = 25-29 years; 4 = 30-34 years; 5 = 35-39
years; and 6 = 40-49 years); maternal race (0 = white; 1 = non-white); maternal education (1 = 0-8 years; 2 = 9-11 years; 3 = 12 years; 4 = 13-15
years; 5 = 16 year and over; 6 = Not stated); interval since last live birth (2 =1-11 months; 3 =12-23 months; 4 =24-35 months; 5 =36-47 months;
6 =48-71 months; 7 =over 72 months; 8 =Not stated); and infant sex (female = 0, male = 1).
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Table C.8: APGAR score (< 7) 5-minute effect of maternal blood lead
(1) (2) (3) (4) (5) (6) (7)
APGAR APGAR APGAR APGAR APGAR APGAR APGAR
Maternal Blood Lead (µg/dL) 0.002*** 0.006*** 0.003***
(0.000) (0.000) (0.000)
ln(Maternal Blood Lead) (µg/dL) 0.041***
(0.004)
Reference (Maternal Blood Lead Q1)
Maternal Blood Lead Q2 0.001*** 0.004*** 0.001***
(0.000) (0.000) (0.000)
Maternal Blood Lead Q3 0.001*** 0.008*** 0.002***
(0.000) (0.000) (0.000)
Maternal Blood Lead Q4 0.002*** 0.010*** 0.003***
(0.000) (0.001) (0.001)
Maternal Blood Lead Q5 0.010*** 0.019*** 0.006***
(0.001) (0.001) (0.001)
Constant -0.006*** -0.049*** -0.017*** -0.076*** 0.016*** 0.009*** 0.021***
(0.002) (0.003) (0.004) (0.010) (0.000) (0.001) (0.001)
Observations 5,270,952 5,270,952 5,270,952 5,270,952 5,270,952 5,270,952 5,270,952
R2 0.00 0.04 0.06 0.06 0.01 0.04 0.06
County FE No Yes Yes Yes No Yes Yes
Year FE No Yes Yes Yes No Yes Yes
Month FE No Yes Yes Yes No Yes Yes
Controls No No Yes Yes No No Yes
Notes: Robust county clustered errors in parentheses *** p < 0.01, ** p < 0.05, * p < 0.1; All models limit to singletons
with plausible gestational length (> 20 weeks); control variables include maternal age (1 = Under 20 years of age; 2 =
20-24 years; 3 = 25-29 years; 4 = 30-34 years; 5 = 35-39 years; and 6 = 40-49 years); maternal race (0 = white; 1 =
non-white); maternal education (1 = 0-8 years; 2 = 9-11 years; 3 = 12 years; 4 = 13-15 years; 5 = 16 year and over;
6 = Not stated); interval since last live birth (2 =1-11 months; 3 =12-23 months; 4 =24-35 months; 5 =36-47 months;
6 =48-71 months; 7 =over 72 months; 8 =Not stated); and infant sex (female = 0, male = 1)
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Figure C.1: Motor Gasoline Survey, summer 1979: Regular grade
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Figure C.2: Motor Gasoline Survey, summer 1979: Unleaded grade
